artes_prrn14a-103008.htm


PRELIMINARY PROXY STATEMENT

SCHEDULE 14A INFORMATION
(RULE 14a-101)
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
Amendment No. 1

Filed by the Registrant [   ]
Filed by a Party other than the Registrant [X]

Check the appropriate box:
[X] Preliminary Proxy Statement
[   ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
[   ] Definitive Proxy Statement
[   ] Definitive Additional Materials
[   ] Soliciting Material Under Rule 14a-12

ARTES MEDICAL, INC.
(Name of Registrant as Specified in Charter)

H. MICHAEL SHACK
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

[X] No fee required.
[   ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1) Title of each class of securities to which transaction applies:
 

 
(2) Aggregate number of securities to which transaction applies:
 

 
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):


 
(4) Proposed maximum aggregate value of transaction:


 
(5) Total fee paid:


 
[   ] Fee paid previously with preliminary materials.


 
[   ] Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1) Amount Previously Paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:
 
 
 

 
 
PRELIMINARY COPY

2008 ANNUAL MEETING OF STOCKHOLDERS

OF

ARTES MEDICAL, INC.



PROXY STATEMENT

OF

H. MICHAEL SHACK

To All Artes Medical, Inc. Stockholders:

This Proxy Statement and the accompanying blue proxy card are being furnished to stockholders (“Stockholders”) of Artes Medical, Inc. (the “Company”) in connection with the solicitation of proxies by H. Michael Shack (the “Proxy Organizer”) to be used at the annual meeting (the “Annual Meeting”) of Stockholders of the Company which, pursuant to the bylaws of the Company, should have been called during the first quarter of 2008.  Since the original filing of this Proxy Statement, the Company has scheduled the Annual Meeting for October 30, 2008, at the San Diego Marriott Del Mar located at 11966 El Camino Real, San Diego, California 92130 at 9:00AM.  The Company’s principal executive offices are located at 5870 Pacific Center Blvd., San Diego, California  92121.  This Proxy Statement and the blue proxy card are first being furnished to Stockholders on or about September 22, 2008.

At the Annual Meeting, the Proxy Organizer will seek to:

1.           Amend the Bylaws of the Company (the "Bylaws") to allow a majority of the Stockholders to fill vacancies on the Board of Directors resulting from the removal of any Directors;

2.           Amend the Bylaws to increase the number of Directors of the Company to 11;

3.           Remove three of the current Directors of the Company under Delaware Corporations Law §141(k)(1) for cause;

4.           Elect four new Directors  to fill the newly created directorships pursuant to proposal #2 of this Proxy Statement or, in the alternative, if proposal #2 is defeated, elect three new Directors to fill the three vacancies created by the removal contained in Proposal #3 of this Proxy Statement;

5.            Vote on the election of two new Class II Directors to serve for three year terms until the annual meeting of Stockholders in 2011 or until their successors are duly elected and qualified; and
 
1


 
6.           Vote on the Nominees’ proposal that the Company may sell up to $20,000,000 of its securities to investors from time to time pursuant to one or more financing transactions.

The Board of Directors is currently comprised of seven members.  The Proxy Organizer is seeking to increase the number of Directors to 11, remove three Directors, and then fill six seats on the Board of Directors through this Proxy.  The Proxy Organizer's nominees are named below under “Election of Directors.”  Each of the nominees (each a “Nominee” and, collectively, the “Nominees”) have been selected by the Proxy Organizer.

The Proxy Organizer is not satisfied with the existing management or Board of Directors of the Company.  He believes that the Company’s poor financial performance, lack of expressed business plan, and questionable changes to key personnel, all as described in the Company’s quarterly and annual reports filed with the Securities and Exchange Commission (the “SEC”), are impairing the Company’s ability to maximize value for all shareholders. 

Section 6.9 of Article 6 of the Bylaws provides that the Bylaws may be amended by the vote of Stockholders.  The Proxy Organizer's proposed amendment to the Bylaws, if approved, will allow vacancies of the Board of Directors to be filled by the vote of a majority of the outstanding shares entitled to vote.  Each director so elected shall hold office until the next annual meeting for the class of each Director of the Company and until a successor has been elected and qualified.

The Proxy Organizer believes that, for the reasons stated below, there is sufficient cause to remove the Directors and it is in the best interest of all of the Stockholders to elect the six new Directors to the Company who provide a track record of success in the dermal filler market and who are experienced in developing a variety of opportunities for the Company and forging a clear direction for the Company. The Proxy Organizer believes that the proposed new Directors provide the necessary industry knowledge in the wrinkle filler markets and will provide a strong sales and marketing background to the Company.  ACCORDINGLY, THE PROXY ORGANIZER IS SOLICITING PROXIES IN FAVOR OF:

1.           Amending the bylaws to allow a majority of shareholder to fill vacancies and newly created directorships on the Board of Directors;

2.           Amending the bylaws to increase the number of Directors to 11;

3.           Remove three of the current Directors for cause;

4.           Elect four new Directors  to fill the newly created directorships pursuant to proposal #2 of this Proxy Statement or, in the alternative, if proposal #2 is defeated, elect three new Directors to fill the three vacancies created by the removal contained in Proposal #3 of this Proxy Statement;

5.           Vote on the election of two new Class II Directors to serve for three year terms until the annual meeting of Stockholders in 2011 or until their successors are duly elected and qualified; and
 
 
2


 
6.  
Vote on the Nominees’ proposal that the Company may sell up to $20,000,000 of its securities to investors from time to time pursuant to one or more financing transactions.


What went wrong with Artes Medical?

· 
According to the NASDAQ Stock Exchange, the Company’s stock price has declined more than 88% in the last 52 weeks.  Within this time period, the Company’s market value has declined from $134.5 million to approximately $15 million, erasing a staggering $119.5 million in shareholder value.  The Company’s share price reached an all-time low of $0.35 on September 16, 2008, down from an all-time high of $9.96 in February 2007.

· 
According to the Company’s Current Report on Form 8-K filed with the SEC on August 22, 2008, on August 19, 2008, the Company received a notice from NASDAQ indicating that its stockholders’ equity on June 30, 2008 was less than the $10 million required for continued listing on The NASDAQ Global Market under Marketplace Rule 4450(a)(3).

· 
According to the Board of Directors’ biographies in the Company’s annual report filed with the SEC, the Company’s current Board of Directors lack any specific industry expertise in the personal aesthetics market.

· 
According to the Company’s reports filed with the SEC, the Board of Directors has made significant personnel changes to the senior management team that had grown the Company from a struggling medical technology start-up to an IPO candidate with a world class, FDA-approved dermal filler product Artefill, replacing them with a management team with little or no relevant industry experience in the dermal filler market.

· 
According to the Company’s reports filed with the SEC, the Company has pledged ALL of its assets against a $22.5 million revenue financing entered into with COWEN Healthcare Royalty Partners (“CHRP”) in January 2008. All assets of Artes Medical will revert to CHRP in case of Artes Medical’s default to service future royalty obligations.

· 
The Company’s management has not acted in a fiscally responsible manner because, among other things, the Company is running out of cash due to, as the Proxy Organizer believes, excessive spending at a rate of approximately $3 million per month as outlined in the financial statements of the Company’s quarterly and annual filings with the SEC.

· 
According to the Company’s reports filed with the SEC, the Company has failed to capitalize on other uses of Artefill beyond personal aesthetics as a means of generating additional opportunities and cash flow for the Company.

· 
The current management and Board of Directors are responsible for canceling a signed distribution agreement on March 5, 2007 with a Taiwanese corporation that would have given the Company a minimum of $4.2 million in combined revenues from sales of Artefill in Taiwan during the first two years of the contract alone.
 
 
 
3


 
· 
The current management and Board of Directors are responsible for forfeiting an estimated minimum of $20 million in additional future royalty revenues from Bioform Medical over the lifetime of the Company’s ‘452 core technology patent by settling for one lump sum payment of $5.5 million which generated a one-time only increase in revenues for the third quarter in 2007 as outlined in the financial statements of the Company’s quarterly and annual filings with the SEC.

· 
According to the 2007 statistics of the American Society For Aesthetic Plastic Surgery (“ASAPS”), the market penetration of Artefill was a dismal 0.7% in 2007 compared to its closest competitor’s 7% for Radiesse® semi-permanent filler marketed by Bioform Medical.  The target number of patients treated with Artefill in year two was initially forecasted at 40,000 patients, however, as indicated in a press release by the Company dated July 28, 2008, only 10,000 patients have been treated within the first 18 months since ArteFill’s U.S. market introduction.

How the new Board of Directors proposes to turn the Company around:

1. 
Engage new senior management to provide leadership and re-establish enthusiasm and morale among employees as well as credibility among customers and the financial community;

2. 
Focus on near-term break-even in the fourth quarter of 2009 through increases in ArteFill sales as well as a significant reduction of cost of goods and operating expenses;

3. 
Implement new and creative sales and marketing strategies for Artefill to reach more aggressive revenue forecasts;

 
4. 
Create ‘ArteFill Centers of Excellence’ within key opinion leaders private practices and organize nationwide and international hands-on, peer-to-peer ArteFill training seminars engaging physician opinion leaders  to re-establish scientific credibility and overcome widespread misconception regarding the use of ArteFill and competitor's discreditation of ArteFill;

 
5. 
Pursue international market opportunities for Artefill;

 
6. 
Remove skin test requirements for ArteFill in collaboration with the FDA;

 
7. 
Develop next generation injectable dermal filler and expand Company’s product portfolio through in-licensing of new and exciting anti-aging technologies; and

 
8. 
Pursue medical pipeline indications such as heartburn (GERD) and spinal disk repair with the Company’s platform technology.

THE NOMINEES ARE COMMITTED TO ACTING IN THE BEST INTERESTS OF THE STOCKHOLDERS.
 
 
4


 
REPRESENTATIVES OF THE NEWLY PROPOSED BOARD OF DIRECTORS AND THEIR PROPOSED CHIEF FINANCIAL OFFICER, WILLIAM KACHIOFF, WILL EXPLAIN THEIR TURN-AROUND STRATEGY AND FINANCIAL MODEL IN MORE DETAIL AT THE ANNUAL MEETING.

THE PROXY ORGANIZER BELIEVES THAT YOUR VOICE IN THE FUTURE OF THE COMPANY CAN BEST BE EXPRESSED THROUGH THE ELECTION OF THE NOMINEES.  ACCORDINGLY, THE PROXY ORGANIZER URGES YOU TO VOTE YOUR BLUE PROXY CARD FOR THE NOMINEES.

IF YOUR SHARES ARE HELD IN THE NAME OF A BROKERAGE FIRM, BANK, BANK NOMINEE OR OTHER INSTITUTION ON THE RECORD DATE, ONLY IT CAN VOTE SUCH SHARES AND ONLY UPON RECEIPT OF YOUR SPECIFIC INSTRUCTIONS.  ACCORDINGLY, PLEASE CONTACT THE PERSON RESPONSIBLE FOR YOUR ACCOUNT AND INSTRUCT THAT PERSON TO EXECUTE ON YOUR BEHALF THE BLUE PROXY CARD AS SOON AS POSSIBLE.
 
 
 
 
 
 
 

 
5

 
 
IMPORTANT

The election of the Nominees requires the affirmative vote of a PLURALITY of the votes cast, assuming a quorum is present or otherwise represented at the Annual Meeting.  As a result, your vote is extremely important in deciding the future of the Company.  The Proxy Organizer urges you to mark, sign, date and return the enclosed blue proxy card to vote for the election of the Nominees.

THE PROXY ORGANIZER URGES YOU NOT TO SIGN ANY PROXY CARD SENT TO YOU BY THE COMPANY.  IF YOU HAVE ALREADY DONE SO, YOU MAY REVOKE YOUR PROXY BY DELIVERING A LATER-DATED BLUE PROXY CARD TO THE PROXY ORGANIZER, OR BY VOTING IN PERSON AT THE ANNUAL MEETING.  SEE "VOTING PROCEDURES" AND "PROXY PROCEDURES" BELOW.

Only holders of record of the Company's voting securities as of the close of business on October 1, 2008 (the "Record Date") are entitled to notice of and to vote at the Annual Meeting and any adjournments or postponements thereof.  According to the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2008, filed with the SEC on May 12, 2008, as of March 31, 2008, there were 16,514,163 shares of common stock outstanding and no shares of preferred stock outstanding.  Stockholders of record at the close of business on the Record Date will be entitled to one vote at the Annual Meeting for each share of common stock (the "Common Stock") held on the Record Date.

As of September 8, 2008, the Proxy Organizer beneficially owned an aggregate of 171,096 shares of Common Stock, representing approximately 1.04% of the outstanding shares of Common Stock.  The Proxy Organizer intends to vote such shares “for” all proposals described in this Proxy Statement. According to the Company’s SEC filings, most of its shareholders own less than 1% of the Company’s common stock.

VOTE FOR ALL PROPOSALS BY RETURNING YOUR COMPLETED BLUE PROXY CARD TODAY.  If you have any questions, you can reach the Proxy Organizer's proxy solicitation firm of MacKenzie Partners, Inc. at (212) 929-5500 or via e-mail at proxy@mackenziepartners.com.

BACKGROUND OF THE PROXY SOLICITATION

Proxy Organizer is submitting proposals for this Proxy Statement which the Proxy Organizer is independently financing.  The Proxy Organizer believes that independently financed proxy solicitations do not require the Company’s approval for submission to the Securities and Exchange Commission or for submission to the Company’s shareholders for a vote on the proposals in Proxy Organizer’s Proxy Statement at the Company’s Annual Meeting.  Proxy Organizer believes this Proxy Statement complies with all substantive and procedural requirements of Article II, Section 2.1 and Section 141(k) of the Delaware General Corporation Law.  Under Delaware General Corporation Law Section 222(a), Proxy Organizer believes that Proxy Organizer is able to raise for the first time and to present any proposals he desires at the Annual Meeting.

 
6

 
In opposition to the current Board of Directors of the Company, the Proxy Organizer is seeking to solicit the proxies of Stockholders to be used to:

1.           Amend the bylaws to allow a majority of shareholder to fill vacancies and newly created directorships on the Board of Directors;

2.           Amend the bylaws to increase the number of Directors to 11;

3.           Remove three of the current Directors for cause;

4.           Elect four new Directors  to fill the newly created directorships pursuant to proposal #2 of this Proxy Statement or, in the alternative, if proposal #2 is defeated, elect three new Directors to fill the three vacancies created by the removal contained in Proposal #3 of this Proxy Statement; and

5.           Vote on the election of two new Class II Directors to serve for three year terms until the annual meeting of Stockholders in 2011 or until their successors are duly elected and qualified.

6.           Vote on the Nominees’ proposal that the Company may sell up to $20,000,000 of its securities to investors from time to time pursuant to one or more financing transactions.

The Nominees, if elected, plan to change the existing management and operations of the Company to effectuate the plan described in this Proxy Statement.  Each of the Nominees has consented to being named in the Proxy Statement, and if so elected, to serve as a Director and is fully committed, if elected, to take such action as the Nominees deem advisable and in the best interests of the Stockholders and which they believe will maximize stockholder value and improve the Company's future viability and growth.

PROPOSAL #1 – FIRST AMENDMENT TO THE BYLAWS

The Company’s Bylaws currently contain this provision:

3.3 Vacancies. Vacancies and newly created directorships resulting from any increase in the authorized number of directors elected by all of the stockholders having the right to vote as a single class may be filled by a majority of the directors then in office, although less than a quorum, or by a sole remaining director. Whenever the holders of any class or classes of stock or series thereof are entitled to elect one or more directors by the provisions of the certificate of incorporation, vacancies and newly created directorships of such class or classes or series may be filled by a majority of the directors elected by such class or classes or series thereof then in office, or by a sole remaining director so elected. The directors so chosen shall hold office until the next annual election and until their successors are duly elected and shall qualify, unless sooner displaced. If there are no directors in office, then an election of directors may be held in the manner provided by statute. If, at the time of filling any vacancy or any newly created directorship, the directors then in office shall constitute less than a majority of the whole Board (as constituted immediately prior to any such increase), the Court of Chancery may, upon application of any stockholder or stockholders holding at least ten percent (10%) of the total number of shares at the time outstanding having the right to vote for such directors, summarily order an election to be held to fill any such vacancies or newly created directorships, or to replace the directors chosen by the directors then in office as aforesaid.

 
7

 
This means that upon the removal of any Directors, the remaining Directors of the Company have the sole and exclusive power to fill those vacancies.

The Proxy Organizer proposes to amend the Bylaws of the Company (the "Bylaws") to allow a majority of the Stockholders to fill vacancies on the Board of Directors resulting from the removal of any Directors.  The new Bylaw provision will read as follows:

3.3 Vacancies. Vacancies and newly created directorships resulting from any increase in the authorized number of directors elected by the stockholders having the right to vote as a single class may be filled by a majority of the shareholders. Whenever the holders of any class or classes of stock or series thereof are entitled to elect one or more directors by the provisions of the certificate of incorporation, vacancies and newly created directorships of such class or classes or series may be filled by a majority of the shareholders. The directors so chosen shall hold office until the next annual election of the each director’s respective class or until their successors are duly elected and shall qualify, unless sooner replaced.

This new bylaw provision will allow a majority of the Stockholders to fill vacancies on the Board of Directors resulting from the removal of any Directors both for the purposes of this proxy as well as in the future.  The Proxy Organizer believes this new provision gives the Stockholders more power to vote on the members of the Board of Directors of the Company.  The Proxy Organizer intends to vote, and recommends that you vote, for this proposal.

PROPOSAL #2 – SECOND AMENDMENT TO THE BYLAWS

The Company’s Bylaws currently contain this provision:

3.2  Number.  Election and Term of Office .  The number of the directors of the Corporation shall not be fewer than three (3) nor more than seven (7), until changed by amendment of the certificate of incorporation or by a bylaw amending this Paragraph 3.2 duly adopted by the vote or written consent of holders of a majority of the outstanding shares entitled to vote. The exact number of directors shall be fixed from time to time, within the limits specified in the certificate of incorporation or in this Section 3.2, by a bylaw or amendment thereof duly adopted by the affirmative vote of the majority of the shares present in person or represented by proxy at a duly held meeting and entitled to vote thereon or by approval of the majority of the shares entitled to vote, or by approval of the board of directors. The directors shall be elected at the annual meeting of the stockholders, except as provided in Paragraph 3.3 of this Article, and each director elected shall hold office until his successor is duly elected and qualified; provided, however, that if the directors shall be divided into classes, each director elected shall hold office until the next election of the class for which such director has been elected, and until his successor has been duly elected and qualified.
 

 
8

 
 
The Proxy Organizer proposes to amend the Bylaws of the Company (the "Bylaws") to increase the Company’s Board of Directors to 11 Directors.  The Nominees will become the Directors for the four newly created Director positions.  The new Bylaw provision will read as follows:

3.2  Number.  Election and Term of Office .  The number of directors of the Corporation shall not be fewer than three (3) nor more than eleven (11), until changed by amendment of the certificate of incorporation or by a bylaw amending this Paragraph 3.2 duly adopted by the vote or written consent of holders of a majority of the outstanding shares entitled to vote. The exact number of directors shall be fixed from time to time, within the limits specified in the certificate of incorporation or in this Section 3.2, by a bylaw or amendment thereof duly adopted by the affirmative vote of the majority of the shares present in person or represented by proxy at a duly held meeting and entitled to vote thereon or by approval of the majority of the shares entitled to vote, or by approval of the board of directors. The directors shall be elected at the annual meeting of the stockholders, except as provided in Paragraph 3.3 of this Article, and each director elected shall hold office until his successor is duly elected and qualified; provided, however, that if the directors shall be divided into classes, each director elected shall hold office until the next election of the class for which such director has been elected, and until his successor has been duly elected and qualified.

This new bylaw provision will allow a majority of the Stockholders to fill the newly created seats on the Board of Directors for the purposes of this proxy as well as in the future.  The Proxy Organizer believes this new provision gives the Stockholders more power to vote on the members of the Board of Directors of the Company.  The Proxy Organizer intends to vote, and recommends that you vote, for this proposal.

PROPOSAL #3 – REMOVAL OF DIRECTORS

The Proxy Organizer proposes to remove Lon E. Otremba, Beverly A. Huss, and Robert B. Shermano as Directors of the Company under Delaware Corporations Law §141(k)(1) for cause.

Delaware General Corporation Law §141(k)(1) reads as follows:
 
(k) Any director or the entire board of directors may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors, except as follows:
 
(1) Unless the certificate of incorporation otherwise provides, in the case of a corporation whose board is classified as provided in subsection (d) of this section, shareholders may effect such removal only for cause.
 
 
9

 
The Company’s Board is classified as provided in subsection (d) of Delaware General Corporation Law §141(k)(1) and, therefore, Directors may be removed only for cause.
 
A “for cause” removal of a director requires that the individual be given: (i) specific charges for his removal, (ii) adequate notice, and (iii) a full opportunity to meet the accusation.
 
The Proxy Organizer believes that these three Directors should be removed for cause because of their breach of fiduciary duty, breach of duty of loyalty, and waste of corporate assets as described in “What Went Wrong with Artes Medical?”.  The Directors have received adequate notice through this Proxy Statement.  Further, each Director has the opportunity to meet the accusation at the Annual Meeting.

The Proxy Organizer believes this proposal is in the best interests of the Stockholders as the Stockholders will then be able to replace the existing Directors of the Company. Therefore, the Proxy Organizer intends to vote, and recommends that you vote, for this proposal.

PROPOSAL #4 – FILL VACANCIES LEFT BY THE REMOVAL OF DIRECTORS

The Proxy Organizer proposes to elect four new Directors of the Company to fill the vacancies created by the increase of the number of directorships to 11 pursuant to proposal #2 of this Proxy Statement.  The Proxy Organizer proposes to elect Terry Knapp, M.D., Barry Vogel, Eric Donsky, and Dr. Johan Brahme to fill the vacancies created by the increase to the number Directors of the Company.

The Proxy Organizer believes these four Director nominees are qualified to serve on the Company’s Board of Directors pursuant to their experience described in their biographies in Proposal #5 below.

Each Nominee, if elected, would hold office until the next annual meeting of shareholders for their respective class or until a successor has been elected and qualified.  Although the Proxy Organizer does not anticipate that any of the persons named below will be unable or unwilling to stand for election, in the event of such occurrence, proxies may be voted for a substitute designated by the Proxy Organizer.  To the extent current members of the Board of Directors do not agree to serve with the Proxy Organizer’s Nominees if the campaign is successful, any vacancies on the Company’s Board of Directors created by resignation of such directors are likely to remain vacant.  The Proxy Organizer currently has no intention to fill any such vacancies.  See Appendix I for additional information about the Nominees, including their ownership, purchase and sale of securities issued by the Company.

The Proxy Organizer intends to vote, and recommends that you vote, for this proposal.

PROPOSAL #5 - ELECTION OF DIRECTORS

According to the Company's proxy statement prepared in connection with the 2007 Annual Meeting of the Company, as filed with the SEC on April 30, 2007 (the "Company's Proxy Statement"), the Company currently has seven Directors, of which the terms of the Class II Directors will expire at the Annual Meeting of the Stockholders.  Christopher J. Reinhard and John R. Costantino are both Class II Directors for the Company and their terms will expire at this Annual Meeting.  The Proxy Organizer proposes that the Stockholders elect Robert Binkele and Charles A. Schliebs to fill the vacancies of the Class II Directors.  The Proxy Organizer believes these two Director nominees are qualified to serve on the Company’s Board of Directors pursuant to their experience described in their biographies below.

 
10

 
Each Nominee, if elected, would hold office until the next annual meeting of shareholders for their respective class or until a successor has been elected and qualified.  Although the Proxy Organizer does not anticipate that any of the persons named below will be unable or unwilling to stand for election, in the event of such occurrence, proxies may be voted for a substitute designated by the Proxy Organizer.  To the extent current members of the Board of Directors do not agree to serve with the Proxy Organizer’s Nominees if the campaign is successful, any vacancies on the Company’s Board of Directors created by resignation of such directors are likely to remain vacant.  The Proxy Organizer has no plan to fill any such vacancies.  See Appendix I for additional information about the Nominees, including their ownership, purchase and sale of securities issued by the Company.

If elected, the Nominees intend to remove the current Chief Financial Officer of the Company and to appoint William Kachioff as the new Chief Financial Officer of the Company.  Background information about Mr. Kachioff is set forth below.

CHARLES A. SCHLIEBS - Mr. Schliebs is the co-founder and Managing Director of iNetworks Advisors, Inc., iNetworks BioOpportunity Fund, LP, and iNetworks Private Fund, LP.  iNetworks is a venture capital/private equity group investing primarily in healthcare/life science ventures in North America.  Prior to co-founding iNetworks, Mr. Schliebs was a partner from 1988 through 1999 with Jones Day, a 2,300-lawyer, international law firm, where he directed the firm’s life sciences practice group worldwide.  Mr. Schliebs’ substantive expertise was as a securities/corporate finance partner and international business law specialist, and his industry specialization was healthcare/life sciences, counseling primarily multinational healthcare/life science companies.  While at Jones Day, Mr. Schliebs was the lawyer responsible for all client service worldwide to Bayer AG, the international pharmaceutical and chemical conglomerate.  Prior to joining Jones Day, Mr. Schliebs served in a variety of executive positions at New York Stock Exchange companies such as Hospital Corporation of America (“HCA”), where he co-founded HCA Venture Capital, the company’s in-house venture arm, investing in emerging healthcare companies.   Over a 24 year legal career, Mr. Schliebs represented a wide variety of healthcare, pharmaceutical, medical device, diagnostic and laboratory/scientific companies.

After concluding his legal career, Mr. Schliebs joined the board of directors of Sunquest Information Systems, Inc., a NASDAQ listed Tucson, Arizona based healthcare information systems company.  In his board role, he oversaw the sale of the company to Misys plc for three times the price of the company’s stock at the time he was asked to join the board.  In addition to serving on the boards of for-profit companies in fields ranging from cardiovascular devices to medical simulation to healthcare IT, he serves on a variety of boards involving entrepreneurship and social issues, including Chatham University’s Center for Women’s Entrepreneurship, Pittsburgh’s Institute for Cross-Cultural Ethics, and the President’s Visiting Committee on Social Justice at West Virginia University.
 
 
11


 
Mr. Schliebs received his J.D. from the Vanderbilt University School of Law, and holds two undergraduate degrees from the University of Pennsylvania, a B.A. and a B.S. in Economics from the Wharton School.

TERRY KNAPP, M.D. - While in Plastic Surgery specialty training at Stanford University, Dr. Knapp developed and patented the enabling technology for Collagen Corporation, which he co-founded in 1975.  While serving as Collagen Corporation’s first VP of Regulatory and Clinical Affairs, he developed the clinical and regulatory strategies that resulted in the first U.S. product approval by the FDA of a Class III medical device under the Medical Device Act of 1976.

Dr. Knapp currently serves as Chairman of the Board of VisioNetx, Inc., a private spin-off from AcuNetx in the field of human impairment testing. Dr. Knapp also has co-founded, and serves as President of the DRL Foundation, Inc., a not-for-profit foundation providing reconstructive surgery and telehealth to developing nations.

Dr. Knapp served as a Director of Collagen Corporation from 1990 through 1996.  Dr. Knapp joined Collagen Corporation and A/W Company of Washington University, St. Louis, in co-founding LipoMatrix, Inc., in 1992 to provide a rationally designed, safe breast implant for women.  From 1992 through 1995, Dr. Knapp served as Chairman, President and CEO of LipoMatrix.  Dr. Knapp established LipoMatrix in both the U.S.A. and in Neuchâtel, Switzerland, where he built the entire corporate infrastructure.  In 1995, LipoMatrix achieved distinction as the first ISO9001 certified breast implant company in the world.  While with LipoMatrix, Dr. Knapp invented the method of tagging medical devices with small passive RFID transponders to provide long-term non-invasive device identification.  Dr. Knapp serves as a founding member of the Board to the Bard Center for Entrepreneurship Development at the University of Colorado, Denver. He recently served on the Advisory Board for the Governor’s Office of Life Sciences and Biotechnology, a component of the Colorado Office of Innovation and Technology. Dr. Knapp also served as a Director of Image Guided Technology, Inc. (NASDAQ: IGTI) until its sale to Stryker Corporation. As founder, Chairman and CEO of PrivaComp, Inc., Dr. Knapp was a finalist for Ernst & Young’s 2002 Entrepreneur of the Year in the Rocky Mountain region.  Dr. Knapp served as Chief Executive Officer of AcuNetx, Inc., a publicly traded, diverse medical device and information technology company with unique products in the fields of eye movement capture and analysis, occupational safety, and osteoplastic surgery and distraction osteogenesis.

During 17 years of reconstructive plastic surgery practice, Dr. Knapp established two craniofacial anomalies panels, established and managed a nationally accredited and Medicare certified outpatient surgery center, and served the community in numerous capacities. Dr. Knapp has been a volunteer surgeon for Interplast, Inc. on 35 trips to developing nations to provide reconstructive surgery for children.  Dr. Knapp founded Vector Health Programs, a community nonprofit, in 1979, and it rapidly became the 13th Medicare accredited hand and upper extremity rehabilitation center in the U.S.
 
12


Dr. Knapp has authored numerous scientific articles, book chapters and op-ed pieces for medical journals, and more than fifteen issued and several pending U.S. and foreign patents, most of them relating to transponder usage for patient-based global medical informatics systems, Internet-based medical communications channels, and for implantable bio-sensor RFID transponder-based data acquisition for physiologic parameter monitoring.

In 1970, Dr. Knapp completed his MD degree at University of Florida.  In 1998, Dr. Knapp became the eighteenth graduate in the history of the University of Florida College of Medicine to be inducted into its Wall of Fame “for noteworthy contributions to medicine, education and to the benefit of the medical consumer.”

ROBERT BINKELE – Mr. Binkele, is the founder and CEO of the Estate Planning Team, Inc.  Estate Planning Team, Inc. has grown to service over 2,200 securities advisors, CPAs, attorneys and other professionals nationwide with tax deferral, estate, and pension planning for their clients.  Mr. Binkele is also a branch manager and investment advisor for J.P. Turner & Co., LLC.  Prior to J.P. Turner & Co, LLC, Mr. Binkele was a branch manager with Brookstreet Securities Corporation.  Prior to Brookstreet Securities Corporation, Mr. Binkele was a top wealth manager at Raymond James Financial Services, Inc. While at Raymond James Financial Services, Inc., he was a member of the Raymond James President’s Council and a member of the US Allianz Chairman’s Council.

Mr. Binkele earned his Bachelor of Science degree with a major in FCS finance from the University of Utah where he was honored as an Academic All American.  He currently serves as the President of the Palm Springs Chapter of the University of Utah Alumni Association.

BARRY VOGEL - In 1997, Mr. Vogel became the President of Canderm, Inc. and vastly increased sales and profitability by restructuring the company.  Under his leadership, Canderm has evolved into the leading privately held skin care company in Canada.  In 1998, Artecoll®, the predecessor to ArteFill, was approved in Canada as the first and only permanent injectable wrinkle filler. Mr. Vogel personally oversaw Artecoll’s market introduction and market development using efficient marketing techniques and extensive hands-on physician training. Mr. Vogel has established Canada as the leading market for Artecoll®/ArteSense® worldwide since its market introduction.  Mr. Vogel is considered a leading marketing expert in the dermal filler industry, having thoroughly researched numerous fillers available throughout the world and distributing a unique and complete portfolio comprising a temporary, semi-permanent and permanent filler (Artecoll/ArteSense).

Barry graduated from Western Ivey Business School in London, Ontario with an HBA (Honors Business Administration) in 1979.

ERIC DONSKY – Mr. Donsky has 15 years experience in building biotechnology and life science companies as a founder and senior manager.  Mr. Donsky is the CEO of OcuSense, Inc., an in-vitro diagnostics company commercializing novel, laboratory-on-a-card technologies that enable eye care practitioners to quantitatively measure biomarkers in tears at the point-of-care so physicians can personalize treatment and objectively track patient outcomes. The Company’s TearLab™ product platform is the first and only system of its kind in the eye care markets. OcuSense is a subsidiary of a public company trading on NASDAQ and TSX and is also certified under ISO 13485. Mr. Donsky also founded Molecular BioSciences (“MBI”). MBI developed a cardiovascular device that was licensed to Medtronic. Mr. Donsky was the founding CEO of Zolaris BioSciences, Inc., an early-stage biotechnology company focused on the discovery and development of therapeutics for the treatment of rheumatoid arthritis, multiple sclerosis, and infectious diseases.  Prior to founding Zolaris, Mr. Donsky was the founding CEO of Applied CarboChemicals, Inc. (“ACC”), an industrial biotechnology company that pioneered the production of chemicals and plastics from renewable resources. ACC has developed the only process capable of economically manufacturing succinic acid through fermentation.
 
 
13


 
Mr. Donsky graduated from Boston University in 1987 with a B.S. in Business Administration.

Johan Brahme, M.D. – Dr. Johan Brahme is a board certified Plastic Surgeon and member of the American Society for Plastic Surgery (ASPS).  He works in La Jolla, California and is a partner at the La Jolla Cosmetic Surgery Center.  Dr. Brahme was among the first U.S. surgeons to incorporate Artefill in his practice and has become an enthusiastic supporter of the product, as well as a longtime shareholder in Artes Medical.

Dr. Brahme and his colleagues are in the process of establishing their La Jolla Cosmetic Surgery Center as the leading ‘Center of Excellence’ for hands-on, peer-to-peer ArteFill injection training as well as organizing practice development seminars regarding the use of injectable wrinkle treatments and other minimal invasive skin rejuvenation procedures.

Dr. Brahme has extensive experience with the clinical use of ArteFill, both in cosmetic and reconstructive applications. Dr Brahme is an innovator and has lectured on the use of ArteFill and its various potential applications on many occasions, both nationally and internationally. He will be instrumental in providing valuable feedback to the Company as to product performance, market perception and training/marketing strategies.

Dr. Brahme received his surgical training at the UCSD School of Medicine and graduated with honors from both the general surgery and plastic surgery program in. Dr. Brahme has an extensive research background and has published in leading peer reviewed medical journals.  Dr. Brahme has also been an active participant in the international surgical relief programs Interface and Fresh Start.

Dr. Brahme is an Associate Clinical Professor of Surgery at UC San Diego School of Medicine and is the past President of the San Diego Plastic Surgery Society.

WILLIAM KACHIOFF (Proposed Chief Financial Officer) – Mr. Kachioff is currently a partner of Tatum, LLC, a national executive services firm focused on the office of the Chief Financial Officer.  Mr. Kachioff has 18 years of experience with extensive operational, financial and management experience.  Mr. Kachioff is the acting Chief Financial Officer at Clarient, Inc.  From 2002 through 2006, Mr. Kachioff was the Chief Financial Officer of Microislet, Inc.  From 1998 through 2001, Mr. Kachioff was the Chief Financial Officer of Cutera, Inc.  Mr. Kachioff has experience in all aspects of financial management, SEC reporting, accounting, legal affairs, treasury, and investor relations for early-stage to mature life science businesses.  Mr. Kachioff has completed a wide variety of financing transactions of approximately $100 million.  Mr. Kachioff built and managed responsive finance operations teams and systems for both public and private companies.
 
 
14


 
The Proxy Organizer intends to vote, and recommends that you vote, for this proposal.

PROPOSAL #6 – PROPOSED FINANCING

The Proxy Organizer’s Nominees realize that the Company needs to raise additional operating capital to proceed with its objectives for the near future.  The Company recently received a notice from The NASDAQ Stock Market (“NASDAQ”) indicating that its stockholders’ equity at June 30, 2008 was less than the $10 million in stockholders’ equity required for continued listing on the NASDAQ Global Market.  The Nominees’ plan for the Company's success in the near future is to complete one or more financing transactions as soon as practical to raise sufficient funds to implement the Nominees plans to turn the Company around as described earlier in this Proxy Statement.

Accordingly, the Nominees propose that the Company sell up to $20,000,000 of its securities to investors from time to time pursuant to one or more financing transactions occurring  (the “Financing”). The Company might issue common stock, warrants to purchase common stock or a new series of preferred stock, or a combination of any of these securities, all as determined by the Nominees.

NASDAQ requires the Company to obtain approval from its stockholders for any financing or series of related financing transactions in which the Company issues 20% or more of its outstanding common stock.   Obtaining stockholder approval of the Financing will facilitate the Company’s efforts to raise funds in a timely manner to allow the Company to raise the funds necessary to support its future operations and turn around plan.  NASDAQ also requires shareholder approval if the financings result in a “change of control” under NASDAQ’s rules.

THE PROXY ORGANIZER INTENDS TO VOTE, AND RECOMMENDS THAT YOU VOTE, FOR THIS PROPOSAL.

INFORMATION REGARDING ALL NOMINEES

All transactions in securities of the Company engaged in by any Nominee during the past two years, as well as current ownership of any such securities by any Nominee, are listed on Appendix I.  No Nominee is a beneficial owner of shares of common stock of the Company.  In addition, and except as stated herein, no Nominee or any of their associates has any agreement or understanding with respect to future employment by the Company, and no such person has any agreement or understanding with respect to any future transactions to which the Company will or may be a party.

Except as described herein, no Nominee nor any of their associates (i) has engaged in or had a direct or indirect interest in any transaction or series of transactions since the beginning of the Company's last fiscal year or in any currently proposed transaction, to which the Company or any of its subsidiaries is a party, (ii) owns beneficially or of record any securities of the Company, (iii) borrowed any funds for the purpose of acquiring or holding any securities of the Company or is presently, or has been within the past year, a party to any contract, arrangement or understanding, with any person with respect to securities of the Company.
 
 
15


 
AGREEMENTS WITH NOMINEES

The Proxy Organizer is entering into letter agreements (the "Nominee Agreements") with each of the Nominees with respect to their service as Nominees, to stand for election as Directors of the Company at the Annual Meeting.  The Nominee Agreements each provide, among other things, as follows:

· 
 The Nominee acknowledges that he has agreed to become a member of the slate of Nominees to stand for election as Directors of the Company in connection with a proxy contest with management of the Company in respect of the election of Directors of the Company at the Annual Meeting;

· 
 The Proxy Organizer agrees to pay the costs of the proxy contest; and

· 
 The Nominee agrees to withdraw as a Nominee of the Proxy Organizer if requested to do so by the Proxy Organizer at any time prior his election as a Director of the Company.

OTHER MATTERS TO BE CONSIDERED AT THE ANNUAL MEETING

Except as set forth above, the Proxy Organizer is not aware of any other proposals to be brought before the Annual Meeting.  Should other proposals be brought before the Annual Meeting, the persons named on the blue proxy card will abstain from voting on such proposals unless such proposals adversely affect the interests of the Proxy Organizer and/or the Nominees as determined by the Proxy Organizer in its sole discretion, in which event such persons will vote on such proposals at their discretion.

VOTING PROCEDURES

Only Stockholders of record as of the Record Date are entitled to notice of and to vote at the Annual Meeting or any adjournments thereof.  On March 31, 2008, there were 16,514,163 shares of Common Stock outstanding. Each share of Common Stock is entitled to one vote on the matters to be presented at the Annual Meeting.

A majority of the shares outstanding must be present in person or by proxy to constitute a quorum at the Annual Meeting.  If a share is represented for any purpose at the Annual Meeting, it is deemed to be present for all other matters.  Abstentions and broker non-votes will be counted for purposes of determining the presence or absence of a quorum.  "Broker Non-votes" are shares held by brokers or nominees which are present in person or represented by proxy, but which are not voted on a particular matter because instructions have not been received from the beneficial owner.  Under applicable Delaware law, the effect of broker nonvotes on a particular matter depends on whether the matter is one as to which the broker or nominee has discretionary voting authority. The effect of broker nonvotes on the specific items to be brought before the Annual Meeting is discussed under each item.
 
 
16


 
According to the Delaware General Corporation Law, directors are elected by a plurality of the votes cast by the holders of Company's Common Stock at a meeting at which a quorum is present, when the bylaws of the Company do not state otherwise.  Plurality means that the number of votes cast for a director in a contest of two or more directors that is greater than the number cast for any other candidate but not more than half the total votes cast.

According to the bylaws of the Company and applicable law, removal of a director and amendments to the bylaws of the Company require a majority vote of the current outstanding shares of the Company.

PROXY PROCEDURES

IN ORDER FOR YOUR VIEWS TO BE REPRESENTED AT THE ANNUAL MEETING, PLEASE MARK, SIGN, DATE AND RETURN THE ENCLOSED BLUE PROXY CARD AND RETURN IT TO PROXY ORGANIZER C/O MACKENZIE PARTNERS, INC. IN THE ENCLOSED POSTAGE-PREPAID ENVELOPE.

The accompanying blue proxy card will be voted at the Annual Meeting in accordance with your instructions on such card.

Any proxy may be revoked at any time prior to the time a vote is taken by delivering to the Secretary of the Company a notice of revocation bearing a later date, by a duly executed proxy bearing a later date or by attending the Annual Meeting and voting in person.

Only holders of record as of the close of business on the Record Date will be entitled to vote.  If you were a Stockholder of record on the Record Date, you will retain your voting rights of the Annual Meeting even if you sell such shares after the Record Date.  Accordingly, it is important that you vote the shares held by you on the Record Date, or grant a proxy to vote such shares on the blue proxy card, even if you sell such shares after the Record Date.

SOLICITATION OF PROXIES

Solicitation of proxies shall be made only by the Proxy Organizer.

The Proxy Organizer has retained MacKenzie Partners, Inc. (the "Solicitor") to conduct the solicitation, for which the Solicitor is to receive a fee of approximately $75,000, plus reimbursement for its reasonable out-of-pocket expenses.  The Proxy Organizer has agreed to indemnify the Solicitor against certain liabilities and expenses, including liabilities under federal securities laws.  Proxies may be solicited by mail, courier services, advertising, telephone, telecopier, e-mail or in person.  It is anticipated that the Solicitor will employ approximately 25 persons to solicit Stockholders for the Annual Meeting.

Costs related to the solicitation of proxies, including expenditures for attorneys, accountants, public relations and financial advisers, proxy solicitors, payments to nominees, advertising, printing, transportation and related expenses and filing fees, will be borne by the Proxy Organizer.  Such costs are expected to be approximately $250,000 in total.  The Proxy Organizer intends to seek reimbursement for the costs and expenses associated with the proxy solicitation in the event that the Nominees are elected to the Board of Directors of the Company, but does not intend to submit the issue of reimbursement to a vote of security holders.

 
17

 
CERTAIN INFORMATION REGARDING PROXY ORGANIZER

On June 30, 2008, the Proxy Organizer determined that he was not satisfied with current management of the Company and decided to explore available options to maximize stockholder value.  The business address of the Proxy Organizer is 19 Burning Tree Road, Newport Beach, CA  92660.

All transactions in the securities of the Company effected within the past two years by Proxy Organizer will be contained in Appendix I.

The Proxy Organizer assumes no responsibility for the accuracy or completeness of any information contained herein which is based on, or incorporated by reference to, the Company's Proxy Statement.

CONCLUSION

If Proposal #1, amendment of the Bylaws of the Company to allow a majority of the Stockholders to fill vacancies or newly created directorships on the Board of Directors, is not passed, Proposals #2, #3, and #4 will become moot as the Stockholders will not be able to fill vacancies on the Board of Directors.  However, even if Proposal #1 is not successful, Proposals #5 and #6 will still be effective as two Class II Directors’ terms are expiring and the Proxy Organizer seeks to elect two new Nominees to these Board seats and the Company will need to sell up to $20,000,000 of its securities to investors from time to time pursuant to one or more financing transactions to continue its operations.

THE PROXY ORGANIZER STRONGLY URGES YOU TO VOTE FOR THE TWO AMENDMENTS TO THE BYLAWS, REMOVAL OF THREE OF THE CURRENT BOARD OF DIRECTORS OF THE COMPANY, THE ELECTION OF THE NOMINEES, AND THE PROPOSED FINANCING BY SIGNING, DATING AND RETURNING THE ENCLOSED PROXY IN THE POSTAGE-PAID ENVELOPE PROVIDED TO YOU WITH THIS PROXY STATEMENT.  IF YOU HAVE SIGNED THE BLUE PROXY CARD AND NO MARKING IS MADE ON IT, YOU WILL BE DEEMED TO HAVE GIVEN A DIRECTION TO VOTE THE SHARES REPRESENTED BY THE BLUE PROXY CARD FOR THE AMENDMENTS TO THE BYLAWS, THE REMOVAL OF THREE OF THE CURRENT BOARD OF DIRECTORS OF THE COMPANY, AND FOR THE ELECTION OF ALL OF THE NOMINEES.

PROXY ORGANIZER



Dr. H. Michael Shack
Date: September 16, 2008
 
 
18

 
IMPORTANT

1.  If your shares are held in your own name, please mark, date and mail the enclosed blue proxy card to the Proxy Organizer, in the postage-paid envelope provided.

2.  If your shares are held in the name of a brokerage firm, bank nominee or other institution, only it can vote such shares and only upon receipt of your specific instructions.  Accordingly, you should contact the person responsible for your account and give instructions for a blue proxy card to be signed representing your shares.

ONLY YOUR LATEST DATED PROXY FOR THE ANNUAL MEETING WILL COUNT AT THE ANNUAL MEETING.





19





 



 
 

 
 
If you have questions or need assistance voting your shares please contact:
 
logo
105 Madison Avenue
New York, New York 10016
proxy@mackenziepartners.com
Call Collect: (212) 929-5500
or
Toll-Free (800) 322-2885
 
 
 
 
 
 
 
 
 
20



 
APPENDIX I

SUPPLEMENTAL NOMINEE AND OTHER INFORMATION

Set forth below is (a) the name and business address of each of the Nominees in the solicitation made pursuant to this Proxy Statement, and (b) the dates, types and amounts of each Nominee’s purchases and sales of the Company's debt and equity securities within the past two years.
 
Name and Business
Address
Transaction
Date
Number of Securities
Purchased
Number of Securities
Sold
Current
Ownership
Dr. H. Michael Shack
1/10/2007
2,500
 
2,500
19 Burning Tree Road
1/10/2007
500
 
3,000
Newport Beach, CA  92660
1/10/2007
2,000
 
5,000
 
1/10/2007
2,500
 
7,500
 
1/10/2007
500
 
8,000
 
1/10/2007
2,000
 
10,000
 
1/11/2007
300
 
10,300
 
1/11/2007
700
 
11,000
 
1/11/2007
300
 
11,300
 
1/11/2007
200
 
11,500
 
1/11/2007
600
 
12,100
 
1/11/2007
 
1,000
11,100
 
1/11/2007
 
1,500
9,600
 
1/11/2007
300
 
9,900
 
1/11/2007
700
 
10,600
 
1/11/2007
300
 
10,900
 
1/17/2007
   
10,900
 
1/17/2007
1,000
 
11,900
 
1/17/2007
 
1,500
10,400
 
1/17/2007
 
1,600
8,800
 
1/17/2007
 
1,500
7,300
 
1/18/2007
1,000
 
8,300
 
1/19/2007
1,000
 
9,300
 
1/19/2007
1,000
 
10,300
 
1/19/2007
1,000
 
11,300
 
1/19/2007
500
 
11,800
 
1/19/2007
500
 
12,300
 
1/19/2007
1,000
 
13,300
 
1/19/2007
 
500
12,800
 
1/19/2007
 
500
12,300
 
1/19/2007
 
1,000
11,300
 
1/19/2007
 
200
11,100
 
1/22/2007
 
1,000
10,100
 
1/22/2007
700
 
10,800
 
1/22/2007
500
 
11,300
 
1/23/2007
 
1,500
9,800
 
1/23/2007
 
1,000
8,800
 
1/23/2007
 
1,500
7,300
 
1/24/2007
1,000
 
8,300
 
1/24/2007
100
 
8,400
 
1/24/2007
900
 
9,300
 
1/24/2007
1,000
 
10,300
 
1/24/2007
 
1,000
9,300
 
1/25/2007
100
 
9,400
 
1/25/2007
250
 
9,650
 
1/25/2007
100
 
9,750
 
1/25/2007
150
 
9,900
 
1/25/2007
200
 
10,100

 
21

 

 
1/25/2007
450
 
10,550
 
1/26/2007
 
100
10,450
 
1/26/2007
 
100
10,350
 
1/26/2007
 
100
10,250
 
1/26/2007
 
100
10,150
 
1/26/2007
 
100
10,050
 
1/26/2007
 
100
9,950
 
1/26/2007
 
100
9,850
 
1/26/2007
 
100
9,750
 
1/26/2007
 
250
9,500
 
1/26/2007
 
400
9,100
 
1/26/2007
200
 
9,300
 
2/1/2007
 
50
9,250
 
2/1/2007
 
400
8,850
 
2/1/2007
 
550
8,300
 
2/1/2007
 
1,000
7,300
 
2/1/2007
200
 
7,500
 
2/1/2007
550
 
8,050
 
2/1/2007
 
750
7,300
 
2/2/2007
800
 
8,100
 
2/2/2007
200
 
8,300
 
2/2/2007
1,500
 
9,800
 
2/2/2007
500
 
10,300
 
2/2/2007
 
1,000
9,300
 
2/2/2007
875
 
10,175
 
2/6/2007
750
 
10,925
 
2/8/2007
1,000
 
11,925
 
2/12/2007
1,500
 
13,425
 
2/12/2007
1,000
 
14,425
 
2/12/2007
1,000
 
15,425
 
2/12/2007
1,500
 
16,925
 
2/12/2007
675
 
17,600
 
2/12/2007
1,000
 
18,600
 
2/12/2007
1,000
 
19,600
 
2/12/2007
500
 
20,100
 
2/12/2007
800
 
20,900
 
2/13/2007
1,000
 
21,900
 
2/13/2007
400
 
22,300
 
2/13/2007
1,000
 
23,300
 
2/13/2007
1,000
 
24,300
 
2/13/2007
1,000
 
25,300
 
2/13/2007
1,000
 
26,300
 
2/13/2007
1,000
 
27,300
 
2/13/2007
1,000
 
28,300
 
2/13/2007
1,000
 
29,300
 
2/15/2007
1,000
 
30,300
 
2/15/2007
1,000
 
31,300
 
2/16/2007
 
180
31,120
 
2/16/2007
 
1,820
29,300

 
22

 


 
2/16/2007
100
 
29,400
 
2/16/2007
900
 
30,300
 
2/16/2007
1,000
 
31,300
 
2/16/2007
350
 
31,650
 
2/16/2007
200
 
31,850
 
2/16/2007
50
 
31,900
 
2/20/2007
25
 
31,925
 
2/20/2007
100
 
32,025
 
2/20/2007
100
 
32,125
 
2/20/2007
100
 
32,225
 
2/20/2007
1,675
 
33,900
 
2/20/2007
1,000
 
34,900
 
2/20/2007
1,000
 
35,900
 
2/20/2007
2,000
 
37,900
 
2/20/2007
 
1,000
36,900
 
2/20/2007
 
1,000
35,900
 
2/20/2007
 
1,000
34,900
 
2/20/2007
 
2,000
32,900
 
2/20/2007
 
2,000
30,900
 
2/21/2007
100
 
31,000
 
2/21/2007
1,500
 
32,500
 
2/21/2007
900
 
33,400
 
2/21/2007
100
 
33,500
 
2/21/2007
1,400
 
34,900
 
2/21/2007
 
1,000
33,900
 
2/22/2007
500
 
34,400
 
2/22/2007
1,500
 
35,900
 
2/22/2007
500
 
36,400
 
2/22/2007
400
 
36,800
 
2/22/2007
100
 
36,900
 
2/22/2007
 
1,500
35,400
 
2/22/2007
 
1,000
34,400
 
2/22/2007
 
1,000
33,400
 
2/22/2007
 
1,000
32,400
 
2/22/2007
 
200
32,200
 
2/22/2007
 
1,795
30,405
 
2/23/2007
1,800
 
32,205
 
2/23/2007
700
 
32,905
 
2/23/2007
465
 
33,370
 
2/23/2007
100
 
33,470
 
2/23/2007
1,935
 
35,405
 
2/23/2007
500
 
35,905
 
2/23/2007
1,000
 
36,905
 
2/23/2007
100
 
37,005
 
2/23/2007
400
 
37,405
 
2/23/2007
500
 
37,905
 
2/23/2007
 
600
37,305
 
2/23/2007
 
100
37,205
 
2/23/2007
 
300
36,905

 
23

 


 
2/23/2007
 
100
36,805
 
2/23/2007
 
1,000
35,805
 
2/23/2007
 
1,000
34,805
 
2/23/2007
100
 
34,905
 
2/23/2007
100
 
35,005
 
2/23/2007
100
 
35,105
 
2/23/2007
100
 
35,205
 
2/23/2007
100
 
35,305
 
2/23/2007
400
 
35,705
 
2/23/2007
300
 
36,005
 
2/23/2007
200
 
36,205
 
2/26/2007
 
3,600
32,605
 
2/26/2007
 
1,400
31,205
 
2/26/2007
2,000
 
33,205
 
2/26/2007
1,000
 
34,205
 
2/26/2007
1,000
 
35,205
 
2/26/2007
1,000
 
36,205
 
2/26/2007
500
 
36,705
 
2/26/2007
100
 
36,805
 
2/26/2007
400
 
37,205
 
2/27/2007
300
 
37,505
 
2/27/2007
2,200
 
39,705
 
2/27/2007
600
 
40,305
 
2/27/2007
190
 
40,495
 
2/27/2007
200
 
40,695
 
2/27/2007
112
 
40,807
 
2/27/2007
300
 
41,107
 
2/27/2007
1,098
 
42,205
 
2/27/2007
1,000
 
43,205
 
2/27/2007
1,500
 
44,705
 
2/27/2007
1,000
 
45,705
 
2/27/2007
2,500
 
48,205
 
2/27/2007
2,500
 
50,705
 
2/27/2007
2,500
 
53,205
 
2/27/2007
400
 
53,605
 
2/27/2007
400
 
54,005
 
2/27/2007
100
 
54,105
 
2/27/2007
100
 
54,205
 
2/27/2007
 
1,000
53,205
 
2/27/2007
 
1,500
51,705
 
2/27/2007
 
117
51,588
 
2/27/2007
 
1,000
50,588
 
2/27/2007
 
2,500
48,088
 
2/27/2007
 
2,500
45,588
 
2/27/2007
 
2,873
42,715
 
2/27/2007
240
 
42,955
 
2/27/2007
500
 
43,455
 
2/27/2007
60
 
43,515
 
2/27/2007
 
3,000
40,515

 
24

 


 
2/28/2007
 
2,215
38,300
 
2/28/2007
 
300
38,000
 
2/28/2007
 
200
37,800
 
3/5/2008
2,000
 
39,800
 
3/5/2008
2,000
 
41,800
 
3/5/2008
2,000
 
43,800
 
3/5/2008
2,000
 
45,800
 
3/5/2008
1,000
 
46,800
 
3/5/2008
650
 
47,450
 
3/5/2008
100
 
47,550
 
3/5/2008
300
 
47,850
 
3/5/2008
950
 
48,800
 
3/5/2008
 
2,100
46,700
 
3/5/2008
 
900
45,800
 
3/5/2008
 
2,000
43,800
 
3/5/2008
 
1,000
42,800
 
3/5/2007
100
 
42,900
 
3/5/2007
100
 
43,000
 
3/5/2007
100
 
43,100
 
3/5/2007
1,329
 
44,429
 
3/5/2007
100
 
44,529
 
3/5/2007
771
 
45,300
 
3/5/2007
300
 
45,600
 
3/5/2007
200
 
45,800
 
3/5/2007
200
 
46,000
 
3/5/2007
100
 
46,100
 
3/5/2007
100
 
46,200
 
3/5/2007
250
 
46,450
 
3/5/2007
800
 
47,250
 
3/5/2007
350
 
47,600
 
3/5/2007
100
 
47,700
 
3/5/2007
50
 
47,750
 
3/6/2007
550
 
48,300
 
3/6/2007
100
 
48,400
 
3/6/2007
400
 
48,800
 
3/6/2007
 
1,500
47,300
 
3/6/2007
 
1,000
46,300
 
3/6/2007
 
1,000
45,300
 
3/6/2007
 
2,000
43,300
 
3/7/2007
1,000
 
44,300
 
3/7/2007
700
 
45,000
 
3/7/2007
300
 
45,300
 
3/7/2007
500
 
45,800
 
3/7/2007
1,000
 
46,800
 
3/7/2007
1,000
 
47,800
 
3/7/2007
700
 
48,500
 
3/7/2007
300
 
48,800
 
3/7/2007
800
 
49,600
 
3/7/2007
100
 
49,700

 
25

 


 
3/7/2007
100
 
49,800
 
3/7/2007
1,000
 
50,800
 
3/7/2007
1,500
 
52,300
 
3/7/2007
1,000
 
53,300
 
3/7/2007
100
 
53,400
 
3/7/2007
100
 
53,500
 
3/7/2007
850
 
54,350
 
3/7/2007
500
 
54,850
 
3/7/2007
200
 
55,050
 
3/7/2007
200
 
55,250
 
3/7/2007
600
 
55,850
 
3/7/2007
100
 
55,950
 
3/7/2007
400
 
56,350
 
3/7/2007
450
 
56,800
 
3/7/2007
100
 
56,900
 
3/7/2007
100
 
57,000
 
3/7/2007
500
 
57,500
 
3/8/2007
2,000
 
59,500
 
3/8/2007
1,500
 
61,000
 
3/8/2007
1,000
 
62,000
 
3/8/2007
400
 
62,400
 
3/8/2007
289
 
62,689
 
3/8/2007
311
 
63,000
 
3/8/2007
100
 
63,100
 
3/8/2007
100
 
63,200
 
3/8/2007
100
 
63,300
 
3/8/2007
100
 
63,400
 
3/9/2007
2,500
 
65,900
 
3/9/2007
1,500
 
67,400
 
3/9/2007
500
 
67,900
 
3/9/2007
1,000
 
68,900
 
3/9/2007
 
2,500
66,400
 
3/9/2007
 
1,000
65,400
 
3/9/2007
 
300
65,100
 
3/9/2007
 
300
64,800
 
3/9/2007
 
100
64,700
 
3/9/2007
 
100
64,600
 
3/9/2007
 
100
64,500
 
3/9/2007
 
100
64,400
 
3/9/2007
 
500
63,900
 
3/9/2007
 
1,600
62,300
 
3/9/2007
250
 
62,550
 
3/12/2007
600
 
63,150
 
3/12/2007
900
 
64,050
 
3/12/2007
1,000
 
65,050
 
3/12/2007
 
1,150
63,900
 
3/12/2007
 
1,100
62,800
 
3/12/2007
 
300
62,500
 
3/12/2007
300
 
62,800

 
26

 


 
3/13/2007
 
120
62,680
 
3/13/2007
 
200
62,480
 
3/13/2007
100
 
62,580
 
3/13/2007
53
 
62,633
 
3/13/2007
47
 
62,680
 
3/13/2007
53
 
62,733
 
3/13/2007
47
 
62,780
 
3/13/2007
100
 
62,880
 
3/13/2007
100
 
62,980
 
3/13/2007
100
 
63,080
 
3/13/2007
100
 
63,180
 
3/13/2007
100
 
63,280
 
3/13/2007
100
 
63,380
 
3/13/2007
100
 
63,480
 
3/13/2007
100
 
63,580
 
3/13/2007
100
 
63,680
 
3/13/2007
800
 
64,480
 
3/13/2007
2,000
 
66,480
 
3/13/2007
2,000
 
68,480
 
3/13/2007
100
 
68,580
 
3/13/2007
1,400
 
69,980
 
3/13/2007
400
 
70,380
 
3/13/2007
71
 
70,451
 
3/13/2007
200
 
70,651
 
3/13/2007
100
 
70,751
 
3/13/2007
229
 
70,980
 
3/13/2007
400
 
71,380
 
3/14/2007
700
 
72,080
 
3/14/2007
 
60
72,020
 
3/14/2007
 
1,400
70,620
 
3/14/2007
500
 
71,120
 
3/14/2007
100
 
71,220
 
3/14/2007
100
 
71,320
 
3/14/2007
100
 
71,420
 
3/14/2007
100
 
71,520
 
3/14/2007
100
 
71,620
 
3/15/2007
132
 
71,752
 
3/15/2007
1,868
 
73,620
 
3/15/2007
 
2,500
71,120
 
3/15/2007
500
 
71,620
 
3/15/2007
1,500
 
73,120
 
3/15/2007
 
586
72,534
 
3/15/2007
500
 
73,034
 
3/15/2007
1,000
 
74,034
 
3/15/2007
800
 
74,834
 
3/15/2007
50
 
74,884
 
3/15/2007
100
 
74,984
 
3/15/2007
200
 
75,184
 
3/15/2007
500
 
75,684

 
27

 


 
3/15/2007
100
 
75,784
 
3/15/2007
235
 
76,019
 
3/15/2007
100
 
76,119
 
3/16/2007
 
1,000
75,119
 
3/16/2007
 
2,000
73,119
 
3/16/2007
 
1,100
72,019
 
3/16/2007
 
300
71,719
 
3/16/2007
 
600
71,119
 
3/16/2007
 
1,000
70,119
 
3/19/2007
 
900
69,219
 
3/20/2007
 
100
69,119
 
3/20/2007
 
900
68,219
 
3/20/2007
600
 
68,819
 
3/20/2007
200
 
69,019
 
3/20/2007
100
 
69,119
 
3/20/2007
100
 
69,219
 
3/21/2007
 
100
69,119
 
3/21/2007
 
800
68,319
 
3/21/2007
 
100
68,219
 
3/21/2007
 
800
67,419
 
3/21/2007
 
500
66,919
 
3/21/2007
 
1,000
65,919
 
3/21/2007
 
1,000
64,919
 
3/21/2007
300
 
65,219
 
3/21/2007
100
 
65,319
 
3/21/2007
300
 
65,619
 
3/21/2007
100
 
65,719
 
3/21/2007
200
 
65,919
 
3/21/2007
200
 
66,119
 
3/21/2007
100
 
66,219
 
3/21/2007
200
 
66,419
 
3/21/2007
100
 
66,519
 
3/21/2007
100
 
66,619
 
3/21/2007
100
 
66,719
 
3/21/2007
100
 
66,819
 
3/21/2007
65
 
66,884
 
3/21/2007
300
 
67,184
 
3/21/2007
215
 
67,399
 
3/21/2007
1,885
 
69,284
 
3/21/2007
100
 
69,384
 
3/21/2007
915
 
70,299
 
3/21/2007
100
 
70,399
 
3/21/2007
100
 
70,499
 
3/21/2007
50
 
70,549
 
3/21/2007
100
 
70,649
 
3/21/2007
750
 
71,399
 
3/22/2007
602
 
72,001
 
3/22/2007
1,898
 
73,899
 
3/22/2007
200
 
74,099

 
28

 


 
3/22/2007
388
 
74,487
 
3/22/2007
1,912
 
76,399
 
3/22/2007
2,500
 
78,899
 
3/22/2007
 
600
78,299
 
3/22/2007
 
1,900
76,399
 
3/22/2007
400
 
76,799
 
3/22/2007
500
 
77,299
 
3/22/2007
1,000
 
78,299
 
3/22/2007
602
 
78,901
 
3/22/2007
1,898
 
80,799
 
3/22/2007
200
 
80,999
 
3/22/2007
388
 
81,387
 
3/22/2007
1,912
 
83,299
 
3/22/2007
2,500
 
85,799
 
3/22/2007
 
600
85,199
 
3/22/2007
 
1,900
83,299
 
3/22/2007
400
 
83,699
 
3/22/2007
500
 
84,199
 
3/22/2007
1,000
 
85,199
 
3/22/2007
500
 
85,699
 
3/22/2007
500
 
86,199
 
3/22/2007
500
 
86,699
 
3/22/2007
500
 
87,199
 
3/22/2007
200
 
87,399
 
3/22/2007
 
100
87,299
 
3/22/2007
 
100
87,199
 
3/22/2007
 
500
86,699
 
3/23/2007
1,200
 
87,899
 
3/23/2007
300
 
88,199
 
3/23/2007
200
 
88,399
 
3/23/2007
2,300
 
90,699
 
3/23/2007
 
2,500
88,199
 
3/23/2007
 
900
87,299
 
3/23/2007
 
1,400
85,899
 
3/23/2007
1,200
 
87,099
 
3/23/2007
300
 
87,399
 
3/23/2007
200
 
87,599
 
3/23/2007
2,300
 
89,899
 
3/23/2007
 
2,500
87,399
 
3/23/2007
 
900
86,499
 
3/23/2007
 
1,400
85,099
 
3/26/2007
 
1,000
84,099
 
3/26/2007
 
1,100
82,999
 
3/26/2007
200
 
83,199
 
3/26/2007
 
2,000
81,199
 
3/26/2007
 
2,000
79,199
 
3/26/2007
 
1,000
78,199
 
3/26/2007
 
1,100
77,099
 
3/26/2007
 
200
76,899

 
29

 


 
3/26/2007
 
2,000
74,899
 
3/26/2007
 
2,000
72,899
 
3/26/2007
 
500
72,399
 
3/26/2007
 
500
71,899
 
3/26/2007
 
655
71,244
 
3/26/2007
 
345
70,899
 
3/26/2007
 
1,500
69,399
 
3/26/2007
 
1,500
67,899
 
3/27/2007
   
67,899
 
3/27/2007
   
67,899
 
3/27/2007
 
1,600
66,299
 
3/27/2007
 
600
65,699
 
3/27/2007
500
 
66,199
 
3/27/2007
100
 
66,299
 
3/27/2007
100
 
66,399
 
3/28/2007
2,500
 
68,899
 
3/28/2007
2,500
 
71,399
 
3/28/2007
300
 
71,699
 
3/28/2007
200
 
71,899
 
3/28/2007
100
 
71,999
 
3/28/2007
100
 
72,099
 
3/28/2007
100
 
72,199
 
3/28/2007
100
 
72,299
 
3/28/2007
100
 
72,399
 
3/28/2007
200
 
72,599
 
3/28/2007
100
 
72,699
 
3/28/2007
100
 
72,799
 
3/28/2007
600
 
73,399
 
3/28/2007
300
 
73,699
 
3/28/2007
 
500
73,199
 
3/28/2007
 
400
72,799
 
3/29/2007
1,000
 
73,799
 
3/29/2007
500
 
74,299
 
3/29/2007
400
 
74,699
 
3/29/2007
900
 
75,599
 
3/29/2007
700
 
76,299
 
3/29/2007
1,500
 
77,799
 
3/29/2007
 
200
77,599
 
3/29/2007
 
100
77,499
 
3/29/2007
 
2,400
75,099
 
3/29/2007
100
 
75,199
 
3/29/2007
1,000
 
76,199
 
3/29/2007
500
 
76,699
 
3/29/2007
400
 
77,099
 
3/29/2007
900
 
77,999
 
3/29/2007
700
 
78,699
 
3/29/2007
1,500
 
80,199
 
3/29/2007
 
200
79,999

 
30

 


 
3/29/2007
 
100
79,899
 
3/29/2007
 
2,400
77,499
 
3/29/2007
 
100
77,399
 
3/29/2007
 
500
76,899
 
3/29/2007
 
100
76,799
 
3/29/2007
 
100
76,699
 
3/29/2007
 
100
76,599
 
3/29/2007
 
200
76,399
 
3/29/2007
 
700
75,699
 
3/29/2007
 
100
75,599
 
3/29/2007
 
100
75,499
 
3/29/2007
 
1,600
73,899
 
3/29/2007
 
100
73,799
 
3/29/2007
 
2,400
71,399
 
3/29/2007
 
2,500
68,899
 
3/29/2007
 
2,000
66,899
 
3/29/2007
100
 
66,999
 
3/29/2007
566
 
67,565
 
3/29/2007
100
 
67,665
 
3/29/2007
400
 
68,065
 
3/29/2007
100
 
68,165
 
3/29/2007
100
 
68,265
 
3/29/2007
100
 
68,365
 
3/29/2007
1,000
 
69,365
 
3/29/2007
34
 
69,399
 
3/29/2007
100
 
69,499
 
3/29/2007
400
 
69,899
 
3/29/2007
2,000
 
71,899
 
3/29/2007
100
 
71,999
 
3/29/2007
400
 
72,399
 
3/29/2007
100
 
72,499
 
3/29/2007
100
 
72,599
 
3/29/2007
300
 
72,899
 
3/29/2007
100
 
72,999
 
3/29/2007
100
 
73,099
 
3/29/2007
100
 
73,199
 
3/29/2007
100
 
73,299
 
3/29/2007
100
 
73,399
 
3/29/2007
100
 
73,499
 
3/29/2007
100
 
73,599
 
3/29/2007
100
 
73,699
 
3/29/2007
200
 
73,899
 
3/29/2007
100
 
73,999
 
3/29/2007
400
 
74,399
 
3/29/2007
100
 
74,499
 
3/29/2007
100
 
74,599

 
31

 


 
3/29/2007
50
 
74,649
 
3/29/2007
100
 
74,749
 
3/29/2007
100
 
74,849
 
3/29/2007
300
 
75,149
 
3/29/2007
100
 
75,249
 
3/29/2007
400
 
75,649
 
3/30/2007
 
400
75,249
 
3/30/2007
 
5,600
69,649
 
3/30/2007
 
700
68,949
 
3/30/2007
 
400
68,549
 
3/30/2007
 
5,600
62,949
 
3/30/2007
 
700
62,249
 
4/2/2007
2,000
 
64,249
 
4/2/2007
2,000
 
66,249
 
4/2/2007
2,000
 
68,249
 
4/2/2007
2,000
 
70,249
 
4/2/2007
200
 
70,449
 
4/2/2007
1,127
 
71,576
 
4/2/2007
 
200
71,376
 
4/2/2007
 
2,000
69,376
 
4/2/2007
 
2,800
66,576
 
4/2/2007
 
77
66,499
 
4/2/2007
 
2,800
63,699
 
4/2/2007
 
1,000
62,699
 
4/2/2007
 
700
61,999
 
4/4/2007
 
2,000
59,999
 
4/4/2007
1,500
 
61,499
 
4/4/2007
2,500
 
63,999
 
4/4/2007
2,000
 
65,999
 
4/4/2007
1,500
 
67,499
 
4/4/2007
 
2,000
65,499
 
4/4/2007
1,500
 
66,999
 
4/4/2007
2,500
 
69,499
 
4/4/2007
2,000
 
71,499
 
4/4/2007
1,500
 
72,999
 
4/4/2007
 
1,900
71,099
 
4/4/2007
 
100
70,999
 
4/4/2007
 
100
70,899
 
4/4/2007
 
100
70,799
 
4/4/2007
 
100
70,699
 
4/4/2007
 
100
70,599
 
4/4/2007
 
100
70,499
 
4/4/2007
 
100
70,399
 
4/4/2007
 
100
70,299
 
4/4/2007
 
100
70,199
 
4/4/2007
 
100
70,099

 
32

 


 
4/4/2007
 
100
69,999
 
4/5/2007
1,000
 
70,999
 
4/5/2007
500
 
71,499
 
4/5/2007
1,000
 
72,499
 
4/5/2007
100
 
72,599
 
4/5/2007
1,900
 
74,499
 
4/5/2007
 
242
74,257
 
4/5/2007
 
2,258
71,999
 
4/5/2007
2,000
 
73,999
 
4/5/2007
500
 
74,499
 
4/5/2007
600
 
75,099
 
4/5/2007
400
 
75,499
 
4/5/2007
500
 
75,999
 
4/5/2007
 
2,500
73,499
 
4/5/2007
 
800
72,699
 
4/5/2007
 
66
72,633
 
4/5/2007
 
134
72,499
 
4/5/2007
1,000
 
73,499
 
4/5/2007
500
 
73,999
 
4/5/2007
1,000
 
74,999
 
4/5/2007
100
 
75,099
 
4/5/2007
1,900
 
76,999
 
4/5/2007
 
242
76,757
 
4/5/2007
 
2,258
74,499
 
4/5/2007
2,000
 
76,499
 
4/5/2007
500
 
76,999
 
4/5/2007
600
 
77,599
 
4/5/2007
400
 
77,999
 
4/5/2007
500
 
78,499
 
4/5/2007
 
2,500
75,999
 
4/5/2007
 
800
75,199
 
4/9/2007
300
 
75,499
 
4/9/2007
1,100
 
76,599
 
4/9/2007
100
 
76,699
 
4/9/2007
200
 
76,899
 
4/9/2007
300
 
77,199
 
4/9/2007
 
1,500
75,699
 
4/10/2007
 
100
75,599
 
4/10/2007
 
3,200
72,399
 
4/10/2007
 
1,000
71,399
 
4/10/2007
 
200
71,199
 
4/10/2007
 
2,000
69,199
 
4/10/2007
 
1,778
67,421
 
4/11/2007
 
1,000
66,421
 
4/11/2007
 
1,122
65,299
 
4/11/2007
 
100
65,199

 
33

 


 
4/12/2007
1,800
 
66,999
 
4/12/2007
700
 
67,699
 
4/13/2007
 
2,500
65,199
 
4/13/2007
1,500
 
66,699
 
4/13/2007
1,400
 
68,099
 
4/13/2007
 
200
67,899
 
4/13/2007
 
1,000
66,899
 
4/17/2007
 
700
66,199
 
4/17/2007
 
1,000
65,199
 
4/17/2007
 
1,000
64,199
 
4/17/2007
5,000
 
69,199
 
4/17/2007
200
 
69,399
 
4/17/2007
800
 
70,199
 
4/17/2007
 
1,000
69,199
 
4/18/2007
600
 
69,799
 
4/18/2007
900
 
70,699
 
4/18/2007
1,000
 
71,699
 
4/18/2007
500
 
72,199
 
4/18/2007
500
 
72,699
 
4/18/2007
1,000
 
73,699
 
4/18/2007
1,200
 
74,899
 
4/18/2007
800
 
75,699
 
4/18/2007
 
1,500
74,199
 
4/18/2007
 
1,500
72,699
 
4/18/2007
 
3,500
69,199
 
4/18/2007
500
 
69,699
 
4/19/2007
1,000
 
70,699
 
4/19/2007
200
 
70,899
 
4/19/2007
300
 
71,199
 
4/19/2007
200
 
71,399
 
4/19/2007
100
 
71,499
 
4/19/2007
100
 
71,599
 
4/19/2007
600
 
72,199
 
4/19/2007
 
100
72,099
 
4/19/2007
 
1,000
71,099
 
4/19/2007
1,200
 
72,299
 
4/19/2007
200
 
72,499
 
4/19/2007
800
 
73,299
 
4/19/2007
200
 
73,499
 
4/20/2007
600
 
74,099
 
4/20/2007
900
 
74,999
 
4/20/2007
1,400
 
76,399
 
4/20/2007
600
 
76,999
 
4/20/2007
1,000
 
77,999
 
4/20/2007
500
 
78,499
 
4/20/2007
100
 
78,599

 
34

 


 
4/20/2007
100
 
78,699
 
4/20/2007
375
 
79,074
 
4/20/2007
425
 
79,499
 
4/20/2007
900
 
80,399
 
4/20/2007
100
 
80,499
 
4/20/2007
1,000
 
81,499
 
4/20/2007
500
 
81,999
 
4/20/2007
 
4,800
77,199
 
4/20/2007
2,500
 
79,699
 
4/20/2007
1,800
 
81,499
 
4/20/2007
700
 
82,199
 
4/20/2007
600
 
82,799
 
4/20/2007
400
 
83,199
 
4/20/2007
100
 
83,299
 
4/20/2007
50
 
83,349
 
4/20/2007
500
 
83,849
 
4/20/2007
100
 
83,949
 
4/23/2007
2,100
 
86,049
 
4/23/2007
900
 
86,949
 
4/23/2007
1,000
 
87,949
 
4/23/2007
1,000
 
88,949
 
4/23/2007
1,000
 
89,949
 
4/23/2007
700
 
90,649
 
4/23/2007
800
 
91,449
 
4/23/2007
1,000
 
92,449
 
4/23/2007
 
3,500
88,949
 
4/23/2007
 
3,000
85,949
 
4/23/2007
400
 
86,349
 
4/23/2007
1,600
 
87,949
 
4/23/2007
500
 
88,449
 
4/23/2007
300
 
88,749
 
4/23/2007
400
 
89,149
 
4/23/2007
300
 
89,449
 
4/23/2007
200
 
89,649
 
4/23/2007
100
 
89,749
 
4/23/2007
100
 
89,849
 
4/23/2007
250
 
90,099
 
4/24/2007
1,000
 
91,099
 
4/24/2007
355
 
91,454
 
4/24/2007
1,145
 
92,599
 
4/24/2007
 
3,000
89,599
 
4/24/2007
 
10,000
79,599
 
4/24/2007
 
750
78,849
 
4/24/2007
600
 
79,449
 
4/25/2007
 
1,000
78,449
 
4/25/2007
 
3,500
74,949
 
4/25/2007
 
2,565
72,384
 
4/25/2007
100
 
72,484

 
35

 


 
4/26/2007
200
 
72,684
 
4/26/2007
2,000
 
74,684
 
4/26/2007
267
 
74,951
 
4/26/2007
233
 
75,184
 
4/26/2007
200
 
75,384
 
4/26/2007
100
 
75,484
 
4/27/2007
 
2,500
72,984
 
4/27/2007
 
635
72,349
 
4/27/2007
2,000
 
74,349
 
4/27/2007
200
 
74,549
 
4/27/2007
1,000
 
75,549
 
4/27/2007
500
 
76,049
 
4/27/2007
200
 
76,249
 
4/27/2007
100
 
76,349
 
4/27/2007
200
 
76,549
 
4/27/2007
100
 
76,649
 
4/27/2007
400
 
77,049
 
4/27/2007
100
 
77,149
 
4/27/2007
100
 
77,249
 
4/27/2007
100
 
77,349
 
4/27/2007
100
 
77,449
 
4/27/2007
200
 
77,649
 
4/27/2007
800
 
78,449
 
4/27/2007
100
 
78,549
 
4/27/2007
200
 
78,749
 
4/27/2007
100
 
78,849
 
4/27/2007
200
 
79,049
 
4/27/2007
100
 
79,149
 
4/27/2007
100
 
79,249
 
4/27/2007
100
 
79,349
 
4/27/2007
200
 
79,549
 
4/27/2007
200
 
79,749
 
4/27/2007
100
 
79,849
 
4/27/2007
100
 
79,949
 
4/27/2007
100
 
80,049
 
4/27/2007
200
 
80,249
 
4/27/2007
100
 
80,349
 
4/27/2007
100
 
80,449
 
4/27/2007
100
 
80,549
 
4/27/2007
200
 
80,749
 
4/27/2007
100
 
80,849
 
4/27/2007
100
 
80,949
 
4/27/2007
100
 
81,049
 
4/27/2007
100
 
81,149
 
4/27/2007
100
 
81,249
 
4/27/2007
100
 
81,349
 
4/27/2007
100
 
81,449
 
4/27/2007
100
 
81,549
 
4/27/2007
1,000
 
82,549

 
36

 


 
4/27/2007
100
 
82,649
 
4/27/2007
100
 
82,749
 
4/27/2007
1,000
 
83,749
 
4/27/2007
300
 
84,049
 
4/27/2007
100
 
84,149
 
4/27/2007
100
 
84,249
 
4/27/2007
10
 
84,259
 
4/27/2007
100
 
84,359
 
4/27/2007
100
 
84,459
 
4/27/2007
100
 
84,559
 
4/27/2007
100
 
84,659
 
4/30/2007
 
100
84,559
 
4/30/2007
2,000
 
86,559
 
4/30/2007
2,100
 
88,659
 
4/30/2007
900
 
89,559
 
4/30/2007
2,000
 
91,559
 
4/30/2007
3,000
 
94,559
 
4/30/2007
500
 
95,059
 
4/30/2007
100
 
95,159
 
4/30/2007
150
 
95,309
 
5/1/2007
1,200
 
96,509
 
5/1/2007
300
 
96,809
 
5/1/2007
 
1,350
95,459
 
5/1/2007
 
400
95,059
 
5/1/2007
 
610
94,449
 
5/1/2007
 
1,500
92,949
 
5/1/2007
500
 
93,449
 
5/2/2007
 
2,500
90,949
 
5/2/2007
 
3,000
87,949
 
5/2/2007
 
2,500
85,449
 
5/2/2007
 
2,500
82,949
 
5/2/2007
 
1,500
81,449
 
5/2/2007
200
 
81,649
 
5/2/2007
100
 
81,749
 
5/2/2007
163
 
81,912
 
5/2/2007
37
 
81,949
 
5/2/2007
1,500
 
83,449
 
5/2/2007
900
 
84,349
 
5/2/2007
100
 
84,449
 
5/2/2007
100
 
84,549
 
5/2/2007
100
 
84,649
 
5/2/2007
800
 
85,449
 
5/2/2007
80
 
85,529
 
5/2/2007
400
 
85,929
 
5/2/2007
20
 
85,949
 
5/2/2007
100
 
86,049
 
5/2/2007
500
 
86,549
 
5/2/2007
400
 
86,949
 
5/2/2007
500
 
87,449

 
37

 


 
5/3/2007
 
2,500
84,949
 
5/3/2007
 
500
84,449
 
5/3/2007
 
2,100
82,349
 
5/3/2007
400
 
82,749
 
5/3/2007
1,100
 
83,849
 
5/3/2007
5,000
 
88,849
 
5/3/2007
7,500
 
96,349
 
5/3/2007
 
1,500
94,849
 
5/3/2007
 
1,500
93,349
 
5/3/2007
 
1,000
92,349
 
5/3/2007
 
900
91,449
 
5/3/2007
 
2,500
88,949
 
5/3/2007
 
1,000
87,949
 
5/3/2007
 
1,100
86,849
 
5/3/2007
100
 
86,949
 
5/3/2007
100
 
87,049
 
5/3/2007
500
 
87,549
 
5/4/2007
 
1,000
86,549
 
5/4/2007
 
1,000
85,549
 
5/4/2007
 
2,000
83,549
 
5/4/2007
 
300
83,249
 
5/4/2007
 
351
82,898
 
5/4/2007
 
349
82,549
 
5/7/2007
500
 
83,049
 
5/7/2007
500
 
83,549
 
5/7/2007
 
4,577
78,972
 
5/7/2007
1,500
 
80,472
 
5/7/2007
500
 
80,972
 
5/7/2007
500
 
81,472
 
5/7/2007
1,500
 
82,972
 
5/7/2007
 
400
82,572
 
5/7/2007
 
2,000
80,572
 
5/7/2007
 
1,500
79,072
 
5/7/2007
100
 
79,172
 
5/7/2007
400
 
79,572
 
5/7/2007
100
 
79,672
 
5/7/2007
100
 
79,772
 
5/7/2007
100
 
79,872
 
5/7/2007
100
 
79,972
 
5/7/2007
100
 
80,072
 
5/7/2007
500
 
80,572
 
5/7/2007
200
 
80,772
 
5/7/2007
100
 
80,872
 
5/7/2007
100
 
80,972
 
5/7/2007
100
 
81,072
 
5/7/2007
500
 
81,572
 
5/8/2007
 
600
80,972
 
5/8/2007
 
100
80,872
 
5/8/2007
 
100
80,772

 
38

 


 
5/8/2007
 
800
79,972
 
5/8/2007
 
400
79,572
 
5/8/2007
200
 
79,772
 
5/8/2007
300
 
80,072
 
5/8/2007
1,100
 
81,172
 
5/8/2007
300
 
81,472
 
5/8/2007
200
 
81,672
 
5/8/2007
130
 
81,802
 
5/8/2007
270
 
82,072
 
5/8/2007
100
 
82,172
 
5/8/2007
100
 
82,272
 
5/8/2007
800
 
83,072
 
5/8/2007
250
 
83,322
 
5/9/2008
 
2,700
80,622
 
5/9/2008
 
1,000
79,622
 
5/9/2008
 
1,500
78,122
 
5/9/2008
 
23
78,099
 
5/9/2008
1,500
 
79,599
 
5/9/2008
 
500
79,099
 
5/9/2008
 
100
78,999
 
5/9/2008
 
100
78,899
 
5/9/2008
 
300
78,599
 
5/9/2008
 
100
78,499
 
5/9/2008
 
100
78,399
 
5/9/2008
 
100
78,299
 
5/9/2008
 
200
78,099
 
5/9/2008
 
100
77,999
 
5/9/2008
 
100
77,899
 
5/9/2008
450
 
78,349
 
5/10/2007
2,500
 
80,849
 
5/10/2007
1,000
 
81,849
 
5/10/2007
2,000
 
83,849
 
5/10/2007
 
2,500
81,349
 
5/10/2007
223
 
81,572
 
5/10/2007
1,477
 
83,049
 
5/10/2007
200
 
83,249
 
5/11/2007
500
 
83,749
 
5/11/2007
 
4,200
79,549
 
5/11/2007
 
500
79,049
 
5/11/2007
50
 
79,099
 
5/14/2007
2,500
 
81,599
 
5/14/2007
2,500
 
84,099
 
5/14/2007
1,500
 
85,599
 
5/14/2007
1,000
 
86,599
 
5/14/2007
200
 
86,799
 
5/14/2007
 
1,500
85,299
 
5/14/2007
100
 
85,399
 
5/14/2007
 
1,000
84,399
 
5/14/2007
200
 
84,599

 
39

 


 
5/14/2007
300
 
84,899
 
5/14/2007
 
5,000
79,899
 
5/14/2007
 
4,179
75,720
 
5/14/2007
 
65
75,655
 
5/14/2007
 
800
74,855
 
5/14/2007
 
2,000
72,855
 
5/14/2007
 
100
72,755
 
5/14/2007
300
 
73,055
 
5/14/2007
100
 
73,155
 
5/14/2007
200
 
73,355
 
5/14/2007
100
 
73,455
 
5/14/2007
100
 
73,555
 
5/14/2007
800
 
74,355
 
5/14/2007
500
 
74,855
 
5/14/2007
300
 
75,155
 
5/14/2007
300
 
75,455
 
5/14/2007
100
 
75,555
 
5/14/2007
10
 
75,565
 
5/14/2007
490
 
76,055
 
5/14/2007
100
 
76,155
 
5/14/2007
100
 
76,255
 
5/14/2007
4,000
 
80,255
 
5/14/2007
1,000
 
81,255
 
5/14/2007
100
 
81,355
 
5/14/2007
470
 
81,825
 
5/14/2007
1,000
 
82,825
 
5/14/2007
21
 
82,846
 
5/15/2007
 
900
81,946
 
5/15/2007
 
100
81,846
 
5/15/2007
 
1,000
80,846
 
5/15/2007
 
1,500
79,346
 
5/15/2007
 
1,500
77,846
 
5/15/2007
500
 
78,346
 
5/15/2007
2,500
 
80,846
 
5/15/2007
300
 
81,146
 
5/15/2007
 
1,500
79,646
 
5/15/2007
 
1,000
78,646
 
5/15/2007
 
800
77,846
 
5/15/2007
 
400
77,446
 
5/15/2007
 
500
76,946
 
5/15/2007
 
100
76,846
 
5/15/2007
 
100
76,746
 
5/15/2007
 
200
76,546
 
5/15/2007
 
200
76,346
 
5/16/2007
1,500
 
77,846
 
5/16/2007
1,000
 
78,846
 
5/16/2007
1,000
 
79,846
 
5/16/2007
405
 
80,251
 
5/16/2007
595
 
80,846

 
40

 


 
5/16/2007
1,500
 
82,346
 
5/16/2007
600
 
82,946
 
5/16/2007
 
1,500
81,446
 
5/17/2007
1,000
 
82,446
 
5/17/2007
1,000
 
83,446
 
5/17/2007
500
 
83,946
 
5/18/2007
 
1,100
82,846
 
5/18/2007
 
1,800
81,046
 
5/18/2007
 
2,404
78,642
 
5/18/2007
 
1,396
77,246
 
5/18/2007
 
1,000
76,246
 
5/18/2007
 
500
75,746
 
5/18/2007
 
1,000
74,746
 
5/18/2007
 
2,500
72,246
 
5/18/2007
2,000
 
74,246
 
5/18/2007
1,500
 
75,746
 
5/18/2007
 
500
75,246
 
5/18/2007
 
100
75,146
 
5/18/2007
 
151
74,995
 
5/18/2007
 
800
74,195
 
5/18/2007
 
1,700
72,495
 
5/18/2007
 
200
72,295
 
5/18/2007
 
100
72,195
 
5/18/2007
 
100
72,095
 
5/18/2007
 
200
71,895
 
5/18/2007
 
100
71,795
 
5/18/2007
 
75
71,720
 
5/18/2007
 
1,200
70,520
 
5/18/2007
 
25
70,495
 
5/18/2007
 
400
70,095
 
5/18/2007
100
 
70,195
 
5/18/2007
28
 
70,223
 
5/18/2007
72
 
70,295
 
5/21/2007
 
2,316
67,979
 
5/21/2007
 
200
67,779
 
5/21/2007
 
100
67,679
 
5/21/2007
 
44
67,635
 
5/21/2007
100
 
67,735
 
5/21/2007
100
 
67,835
 
5/21/2007
300
 
68,135
 
5/22/2007
650
 
68,785
 
5/22/2007
2,500
 
71,285
 
5/22/2007
1,500
 
72,785
 
5/22/2007
450
 
73,235
 
5/22/2007
210
 
73,445
 
5/23/2007
1,000
 
74,445
 
5/23/2007
800
 
75,245
 
5/23/2007
200
 
75,445
 
5/23/2007
400
 
75,845

 
41

 


 
5/23/2007
100
 
75,945
 
5/23/2007
1,100
 
77,045
 
5/23/2007
350
 
77,395
 
5/23/2007
300
 
77,695
 
5/23/2007
150
 
77,845
 
5/24/2007
500
 
78,345
 
5/24/2007
 
1,000
77,345
 
5/24/2007
 
1,500
75,845
 
5/24/2007
 
1,500
74,345
 
5/24/2007
500
 
74,845
 
5/24/2007
 
1,500
73,345
 
5/24/2007
 
108
73,237
 
5/24/2007
 
100
73,137
 
5/24/2007
 
291
72,846
 
5/25/2007
500
 
73,346
 
5/25/2007
1,000
 
74,346
 
5/25/2007
500
 
74,846
 
5/25/2007
600
 
75,446
 
5/25/2007
100
 
75,546
 
5/25/2007
300
 
75,846
 
5/29/2007
2,000
 
77,846
 
5/29/2007
 
3,500
74,346
 
5/29/2007
100
 
74,446
 
5/29/2007
200
 
74,646
 
5/29/2007
200
 
74,846
 
5/30/2007
500
 
75,346
 
5/30/2007
1,000
 
76,346
 
5/30/2007
1,000
 
77,346
 
5/30/2007
1,500
 
78,846
 
5/30/2007
500
 
79,346
 
5/30/2007
 
1,000
78,346
 
5/30/2007
 
1,000
77,346
 
5/30/2007
 
1,000
76,346
 
5/31/2007
 
2,900
73,446
 
5/31/2007
 
1,100
72,346
 
5/31/2007
 
1,350
70,996
 
5/31/2007
 
1,000
69,996
 
5/31/2007
 
650
69,346
 
5/31/2007
150
 
69,496
 
6/1/2007
 
100
69,396
 
6/1/2007
 
1,900
67,496
 
6/1/2007
 
400
67,096
 
6/1/2007
 
600
66,496
 
6/1/2007
 
1,000
65,496
 
6/1/2007
 
500
64,996
 
6/1/2007
 
500
64,496
 
6/1/2007
1,000
 
65,496
 
6/1/2007
55
 
65,551
 
6/1/2007
100
 
65,651

 
42

 


 
6/1/2007
100
 
65,751
 
6/1/2007
100
 
65,851
 
6/1/2007
45
 
65,896
 
6/1/2007
100
 
65,996
 
6/1/2007
1,100
 
67,096
 
6/1/2007
400
 
67,496
 
6/1/2007
500
 
67,996
 
6/1/2007
500
 
68,496
 
6/1/2007
850
 
69,346
 
6/4/2007
1,500
 
70,846
 
6/5/2007
500
 
71,346
 
6/6/2007
 
1,500
69,846
 
6/6/2007
300
 
70,146
 
6/6/2007
200
 
70,346
 
6/6/2007
300
 
70,646
 
6/6/2007
1,000
 
71,646
 
6/6/2007
500
 
72,146
 
6/6/2007
700
 
72,846
 
6/6/2007
300
 
73,146
 
6/6/2007
500
 
73,646
 
6/6/2007
500
 
74,146
 
6/7/2007
1,500
 
75,646
 
6/7/2007
500
 
76,146
 
6/7/2007
200
 
76,346
 
6/7/2007
100
 
76,446
 
6/7/2007
446
 
76,892
 
6/8/2007
 
200
76,692
 
6/11/2007
1,000
 
77,692
 
6/11/2007
200
 
77,892
 
6/11/2007
 
1,500
76,392
 
6/11/2007
 
1,500
74,892
 
6/11/2007
 
900
73,992
 
6/11/2007
 
100
73,892
 
6/11/2007
 
100
73,792
 
6/11/2007
 
100
73,692
 
6/11/2007
 
100
73,592
 
6/11/2007
 
800
72,792
 
6/11/2007
 
548
72,244
 
6/11/2007
300
 
72,544
 
6/11/2007
300
 
72,844
 
6/12/2007
 
1,100
71,744
 
6/12/2007
1,500
 
73,244
 
6/12/2007
2,500
 
75,744
 
6/12/2007
2,400
 
78,144
 
6/12/2007
100
 
78,244
 
6/12/2007
 
500
77,744
 
6/12/2007
 
800
76,944
 
6/12/2007
 
4,900
72,044
 
6/13/2007
200
 
72,244

 
43

 


 
6/13/2007
200
 
72,444
 
6/13/2007
300
 
72,744
 
6/13/2007
 
498
72,246
 
6/13/2007
200
 
72,446
 
6/14/2007
1,500
 
73,946
 
6/14/2007
1,000
 
74,946
 
6/14/2007
500
 
75,446
 
6/14/2007
300
 
75,746
 
6/14/2007
200
 
75,946
 
6/14/2007
 
2,500
73,446
 
6/14/2007
200
 
73,646
 
6/14/2007
 
1,000
72,646
 
6/14/2007
1,000
 
73,646
 
6/14/2007
100
 
73,746
 
6/14/2007
200
 
73,946
 
6/14/2007
100
 
74,046
 
6/14/2007
100
 
74,146
 
6/14/2007
100
 
74,246
 
6/14/2007
200
 
74,446
 
6/14/2007
200
 
74,646
 
6/14/2007
100
 
74,746
 
6/14/2007
100
 
74,846
 
6/14/2007
100
 
74,946
 
6/14/2007
100
 
75,046
 
6/14/2007
200
 
75,246
 
6/14/2007
300
 
75,546
 
6/15/2007
 
200
75,346
 
6/15/2007
100
 
75,446
 
6/15/2007
2,500
 
77,946
 
6/15/2007
 
1,000
76,946
 
6/15/2007
 
3,000
73,946
 
6/15/2007
200
 
74,146
 
6/15/2007
300
 
74,446
 
6/18/2007
 
1,400
73,046
 
6/18/2007
 
900
72,146
 
6/18/2007
 
3,200
68,946
 
6/18/2007
 
1,358
67,588
 
6/18/2007
 
1,142
66,446
 
6/18/2007
 
100
66,346
 
6/18/2007
 
63
66,283
 
6/18/2007
 
100
66,183
 
6/18/2007
 
100
66,083
 
6/18/2007
 
1,000
65,083
 
6/18/2007
 
1,000
64,083
 
6/18/2007
 
100
63,983
 
6/18/2007
 
100
63,883
 
6/18/2007
 
100
63,783
 
6/18/2007
 
100
63,683
 
6/18/2007
 
100
63,583

 
44

 


 
6/18/2007
 
100
63,483
 
6/18/2007
 
100
63,383
 
6/18/2007
 
800
62,583
 
6/18/2007
100
 
62,683
 
6/18/2007
100
 
62,783
 
6/18/2007
100
 
62,883
 
6/18/2007
300
 
63,183
 
6/18/2007
100
 
63,283
 
6/18/2007
200
 
63,483
 
6/18/2007
200
 
63,683
 
6/19/2007
2,500
 
66,183
 
6/19/2007
1,500
 
67,683
 
6/19/2007
500
 
68,183
 
6/19/2007
1,000
 
69,183
 
6/19/2007
500
 
69,683
 
6/19/2007
 
2,400
67,283
 
6/19/2007
 
200
67,083
 
6/19/2007
 
400
66,683
 
6/19/2007
 
100
66,583
 
6/19/2007
 
100
66,483
 
6/19/2007
 
100
66,383
 
6/19/2007
 
400
65,983
 
6/19/2007
 
100
65,883
 
6/19/2007
 
100
65,783
 
6/19/2007
 
200
65,583
 
6/19/2007
 
100
65,483
 
6/19/2007
 
300
65,183
 
6/19/2007
 
100
65,083
 
6/19/2007
 
200
64,883
 
6/19/2007
100
 
64,983
 
6/19/2007
100
 
65,083
 
6/19/2007
500
 
65,583
 
6/19/2007
100
 
65,683
 
6/19/2007
200
 
65,883
 
6/19/2007
100
 
65,983
 
6/19/2007
100
 
66,083
 
6/19/2007
100
 
66,183
 
6/19/2007
100
 
66,283
 
6/19/2007
100
 
66,383
 
6/19/2007
100
 
66,483
 
6/19/2007
540
 
67,023
 
6/19/2007
100
 
67,123
 
6/19/2007
200
 
67,323
 
6/19/2007
60
 
67,383
 
6/19/2007
300
 
67,683
 
6/19/2007
600
 
68,283
 
6/19/2007
100
 
68,383
 
6/20/2007
500
 
68,883
 
6/20/2007
3,400
 
72,283

 
45

 


 
6/20/2007
100
 
72,383
 
6/20/2007
1,000
 
73,383
 
6/20/2007
 
2,000
71,383
 
6/20/2007
500
 
71,883
 
6/20/2007
1,400
 
73,283
 
6/20/2007
100
 
73,383
 
6/20/2007
100
 
73,483
 
6/20/2007
100
 
73,583
 
6/20/2007
200
 
73,783
 
6/20/2007
100
 
73,883
 
6/20/2007
150
 
74,033
 
6/20/2007
350
 
74,383
 
6/20/2007
100
 
74,483
 
6/20/2007
200
 
74,683
 
6/20/2007
100
 
74,783
 
6/20/2007
100
 
74,883
 
6/20/2007
300
 
75,183
 
6/20/2007
363
 
75,546
 
6/21/2007
1,000
 
76,546
 
6/21/2007
200
 
76,746
 
6/21/2007
1,800
 
78,546
 
6/21/2007
1,000
 
79,546
 
6/21/2007
1,500
 
81,046
 
6/21/2007
1,500
 
82,546
 
6/21/2007
1,000
 
83,546
 
6/21/2007
200
 
83,746
 
6/21/2007
500
 
84,246
 
6/21/2007
 
1,634
82,612
 
6/21/2007
1,000
 
83,612
 
6/21/2007
500
 
84,112
 
6/21/2007
 
2,000
82,112
 
6/21/2007
 
100
82,012
 
6/21/2007
 
100
81,912
 
6/21/2007
 
100
81,812
 
6/21/2007
 
100
81,712
 
6/21/2007
 
100
81,612
 
6/21/2007
 
100
81,512
 
6/21/2007
 
100
81,412
 
6/21/2007
 
100
81,312
 
6/21/2007
 
7,400
73,912
 
6/21/2007
 
1,600
72,312
 
6/21/2007
 
800
71,512
 
6/21/2007
 
2,000
69,512
 
6/21/2007
135
 
69,647
 
6/21/2007
65
 
69,712
 
6/21/2007
100
 
69,812
 
6/21/2007
100
 
69,912
 
6/21/2007
100
 
70,012
 
6/21/2007
200
 
70,212

 
46

 


 
6/21/2007
100
 
70,312
 
6/21/2007
100
 
70,412
 
6/21/2007
100
 
70,512
 
6/21/2007
10
 
70,522
 
6/21/2007
90
 
70,612
 
6/21/2007
1,300
 
71,912
 
6/21/2007
300
 
72,212
 
6/21/2007
100
 
72,312
 
6/21/2007
170
 
72,482
 
6/21/2007
30
 
72,512
 
6/21/2007
70
 
72,582
 
6/21/2007
100
 
72,682
 
6/21/2007
100
 
72,782
 
6/21/2007
100
 
72,882
 
6/21/2007
830
 
73,712
 
6/21/2007
100
 
73,812
 
6/21/2007
100
 
73,912
 
6/21/2007
100
 
74,012
 
6/21/2007
100
 
74,112
 
6/21/2007
100
 
74,212
 
6/21/2007
100
 
74,312
 
6/21/2007
100
 
74,412
 
6/21/2007
2,000
 
76,412
 
6/21/2007
100
 
76,512
 
6/21/2007
100
 
76,612
 
6/21/2007
100
 
76,712
 
6/21/2007
100
 
76,812
 
6/21/2007
100
 
76,912
 
6/21/2007
100
 
77,012
 
6/21/2007
100
 
77,112
 
6/22/2007
2,500
 
79,612
 
6/22/2007
1,500
 
81,112
 
6/22/2007
1,500
 
82,612
 
6/22/2007
2,500
 
85,112
 
6/22/2007
100
 
85,212
 
6/22/2007
100
 
85,312
 
6/22/2007
100
 
85,412
 
6/22/2007
700
 
86,112
 
6/22/2007
250
 
86,362
 
6/25/2007
400
 
86,762
 
6/25/2007
1,600
 
88,362
 
6/25/2007
 
1,000
87,362
 
6/25/2007
1,000
 
88,362
 
6/25/2007
600
 
88,962
 
6/25/2007
400
 
89,362
 
6/25/2007
 
1,000
88,362
 
6/25/2007
 
5,000
83,362
 
6/25/2007
 
1,250
82,112
 
6/25/2008
 
100
82,012

 
47

 


 
6/25/2007
300
 
82,312
 
6/26/2007
 
100
82,212
 
6/26/2007
 
1,535
80,677
 
6/26/2007
 
100
80,577
 
6/26/2007
200
 
80,777
 
6/26/2007
300
 
81,077
 
6/27/2007
500
 
81,577
 
6/27/2007
300
 
81,877
 
6/27/2007
900
 
82,777
 
6/27/2007
600
 
83,377
 
6/27/2007
100
 
83,477
 
6/27/2007
100
 
83,577
 
6/27/2007
100
 
83,677
 
6/27/2007
100
 
83,777
 
6/27/2007
100
 
83,877
 
6/27/2007
100
 
83,977
 
6/27/2007
100
 
84,077
 
6/27/2007
100
 
84,177
 
6/27/2007
300
 
84,477
 
6/27/2007
500
 
84,977
 
6/27/2007
500
 
85,477
 
6/27/2007
500
 
85,977
 
6/27/2007
300
 
86,277
 
6/27/2007
300
 
86,577
 
6/27/2007
900
 
87,477
 
6/27/2007
100
 
87,577
 
6/27/2007
400
 
87,977
 
6/27/2007
300
 
88,277
 
6/27/2007
200
 
88,477
 
6/27/2007
300
 
88,777
 
6/27/2007
100
 
88,877
 
6/27/2007
100
 
88,977
 
6/27/2007
100
 
89,077
 
6/27/2007
100
 
89,177
 
6/27/2007
100
 
89,277
 
6/27/2007
100
 
89,377
 
6/27/2007
100
 
89,477
 
6/27/2007
400
 
89,877
 
6/27/2007
49
 
89,926
 
6/27/2007
100
 
90,026
 
6/27/2007
251
 
90,277
 
6/27/2007
200
 
90,477
 
6/27/2007
100
 
90,577
 
6/27/2007
100
 
90,677
 
6/27/2007
100
 
90,777
 
6/27/2007
100
 
90,877
 
6/27/2007
100
 
90,977
 
6/27/2007
1,000
 
91,977
 
6/27/2007
1,000
 
92,977

 
48

 


 
6/27/2007
 
2,300
90,677
 
6/28/2007
 
1,500
89,177
 
6/28/2007
 
3,400
85,777
 
6/28/2007
 
100
85,677
 
6/28/2007
 
2,900
82,777
 
6/28/2007
 
500
82,277
 
6/28/2007
 
1,000
81,277
 
6/28/2007
100
 
81,377
 
6/28/2007
100
 
81,477
 
6/28/2007
100
 
81,577
 
6/28/2007
200
 
81,777
 
6/28/2007
100
 
81,877
 
6/28/2007
100
 
81,977
 
6/28/2007
1,500
 
83,477
 
6/28/2007
100
 
83,577
 
6/28/2007
700
 
84,277
 
6/28/2007
500
 
84,777
 
6/29/2007
 
2,500
82,277
 
6/29/2007
 
370
81,907
 
6/29/2007
 
700
81,207
 
6/29/2007
 
895
80,312
 
6/29/2007
 
585
79,727
 
6/29/2007
 
300
79,427
 
6/29/2007
 
41
79,386
 
6/29/2007
 
100
79,286
 
6/29/2007
 
1,850
77,436
 
6/29/2007
 
415
77,021
 
7/2/2007
100
 
77,121
 
7/2/2007
600
 
77,721
 
7/2/2007
800
 
78,521
 
7/2/2007
1,500
 
80,021
 
7/2/2007
400
 
80,421
 
7/2/2007
44
 
80,465
 
7/2/2007
400
 
80,865
 
7/2/2007
100
 
80,965
 
7/2/2007
 
400
80,565
 
7/2/2007
500
 
81,065
 
7/2/2007
500
 
81,565
 
7/2/2007
590
 
82,155
 
7/2/2007
1,000
 
83,155
 
7/2/2007
 
1,200
81,955
 
7/3/2008
1,000
 
82,955
 
7/3/2008
1,000
 
83,955
 
7/3/2008
500
 
84,455
 
7/3/2007
500
 
84,955
 
7/3/2007
100
 
85,055
 
7/3/2007
200
 
85,255
 
7/3/2007
200
 
85,455
 
7/3/2007
500
 
85,955

 
49

 


 
7/3/2007
300
 
86,255
 
7/3/2007
300
 
86,555
 
7/5/2007
400
 
86,955
 
7/5/2007
500
 
87,455
 
7/6/2007
200
 
87,655
 
7/6/2007
300
 
87,955
 
7/6/2007
500
 
88,455
 
7/6/2007
500
 
88,955
 
7/6/2007
 
1,000
87,955
 
7/6/2007
 
300
87,655
 
7/6/2007
200
 
87,855
 
7/6/2007
100
 
87,955
 
7/6/2007
100
 
88,055
 
7/6/2007
100
 
88,155
 
7/6/2007
500
 
88,655
 
7/9/2007
200
 
88,855
 
7/9/2007
100
 
88,955
 
7/9/2007
100
 
89,055
 
7/9/2007
100
 
89,155
 
7/9/2007
1,000
 
90,155
 
7/10/2007
500
 
90,655
 
7/10/2007
500
 
91,155
 
7/10/2007
500
 
91,655
 
7/10/2007
1,000
 
92,655
 
7/10/2007
1,000
 
93,655
 
7/10/2007
 
2,700
90,955
 
7/11/2007
 
1,000
89,955
 
7/11/2007
 
5,300
84,655
 
7/11/2007
 
300
84,355
 
7/12/2007
 
900
83,455
 
7/12/2007
 
400
83,055
 
7/12/2007
 
100
82,955
 
7/12/2007
400
 
83,355
 
7/12/2007
500
 
83,855
 
7/13/2007
1,000
 
84,855
 
7/13/2007
1,000
 
85,855
 
7/13/2007
400
 
86,255
 
7/13/2007
1,100
 
87,355
 
7/13/2007
1,000
 
88,355
 
7/13/2007
 
100
88,255
 
7/13/2007
500
 
88,755
 
7/13/2007
500
 
89,255
 
7/13/2007
50
 
89,305
 
7/13/2007
450
 
89,755
 
7/16/2007
 
500
89,255
 
7/16/2007
 
1,000
88,255
 
7/16/2007
 
1,000
87,255
 
7/16/2007
 
800
86,455
 
7/16/2007
 
200
86,255

 
50

 


 
7/16/2007
100
 
86,355
 
7/16/2007
100
 
86,455
 
7/16/2007
700
 
87,155
 
7/17/2007
 
500
86,655
 
7/17/2007
 
400
86,255
 
7/17/2007
 
400
85,855
 
7/17/2007
 
3,700
82,155
 
7/17/2007
600
 
82,755
 
7/17/2007
350
 
83,105
 
7/17/2007
20
 
83,125
 
7/17/2007
130
 
83,255
 
7/17/2007
500
 
83,755
 
7/17/2007
200
 
83,955
 
7/18/2007
169
 
84,124
 
7/18/2007
831
 
84,955
 
7/18/2007
 
3,000
81,955
 
7/18/2007
1,000
 
82,955
 
7/18/2007
500
 
83,455
 
7/18/2007
300
 
83,755
 
7/18/2007
100
 
83,855
 
7/18/2007
100
 
83,955
 
7/18/2007
100
 
84,055
 
7/18/2007
100
 
84,155
 
7/18/2007
100
 
84,255
 
7/18/2007
200
 
84,455
 
7/19/2007
36
 
84,491
 
7/19/2007
164
 
84,655
 
7/19/2007
 
200
84,455
 
7/19/2007
 
2,000
82,455
 
7/19/2007
500
 
82,955
 
7/19/2007
1,000
 
83,955
 
7/19/2007
100
 
84,055
 
7/19/2007
100
 
84,155
 
7/19/2007
100
 
84,255
 
7/19/2007
100
 
84,355
 
7/19/2007
100
 
84,455
 
7/19/2007
100
 
84,555
 
7/19/2007
100
 
84,655
 
7/20/2007
 
1,500
83,155
 
7/20/2007
 
2,100
81,055
 
7/20/2007
 
700
80,355
 
7/20/2007
 
900
79,455
 
7/20/2007
 
100
79,355
 
7/20/2007
 
1,027
78,328
 
7/20/2007
 
100
78,228
 
7/20/2007
 
100
78,128
 
7/20/2007
 
150
77,978
 
7/23/2007
 
1,000
76,978
 
7/23/2007
500
 
77,478

 
51

 


 
7/23/2007
250
 
77,728
 
7/23/2007
100
 
77,828
 
7/23/2007
500
 
78,328
 
7/23/2007
150
 
78,478
 
7/23/2007
477
 
78,955
 
7/24/2007
700
 
79,655
 
7/24/2007
400
 
80,055
 
7/24/2007
100
 
80,155
 
7/24/2007
500
 
80,655
 
7/24/2007
1,000
 
81,655
 
7/24/2007
500
 
82,155
 
7/24/2007
500
 
82,655
 
7/24/2007
50
 
82,705
 
7/24/2007
150
 
82,855
 
7/25/2007
 
100
82,755
 
7/25/2007
 
100
82,655
 
7/25/2007
 
500
82,155
 
7/25/2007
 
8,200
73,955
 
7/27/2007
500
 
74,455
 
7/27/2007
1,000
 
75,455
 
7/27/2007
1,000
 
76,455
 
7/30/2007
500
 
76,955
 
7/30/2007
 
1,500
75,455
 
7/30/2007
 
10
75,445
 
7/30/2007
 
100
75,345
 
7/30/2007
 
100
75,245
 
7/30/2007
 
100
75,145
 
7/30/2007
 
200
74,945
 
7/30/2007
 
100
74,845
 
7/30/2007
 
400
74,445
 
7/30/2007
 
300
74,145
 
7/30/2007
 
90
74,055
 
7/30/2007
 
100
73,955
 
7/30/2007
 
350
73,605
 
7/31/2007
 
1,500
72,105
 
7/31/2007
149
 
72,254
 
7/31/2007
100
 
72,354
 
7/31/2007
200
 
72,554
 
7/31/2007
200
 
72,754
 
7/31/2007
300
 
73,054
 
8/1/2007
1,000
 
74,054
 
8/1/2007
1,500
 
75,554
 
8/1/2007
1,500
 
77,054
 
8/1/2007
2,500
 
79,554
 
8/1/2007
1,500
 
81,054
 
8/1/2007
2,000
 
83,054
 
8/1/2007
1,000
 
84,054
 
8/1/2007
100
 
84,154
 
8/1/2007
1
 
84,155

 
52

 


 
8/1/2007
99
 
84,254
 
8/1/2007
1
 
84,255
 
8/2/2007
 
5,000
79,255
 
8/3/2007
1,500
 
80,755
 
8/3/2007
2,000
 
82,755
 
8/3/2007
 
1,800
80,955
 
8/3/2007
 
850
80,105
 
8/3/2007
 
1,960
78,145
 
8/3/2007
 
200
77,945
 
8/3/2007
 
100
77,845
 
8/3/2007
 
90
77,755
 
8/3/2007
 
172
77,583
 
8/3/2007
 
4,078
73,505
 
8/3/2007
 
100
73,405
 
8/3/2007
 
100
73,305
 
8/3/2007
 
100
73,205
 
8/3/2007
 
100
73,105
 
8/3/2007
 
5,000
68,105
 
8/3/2007
 
1,000
67,105
 
8/3/2007
 
1,000
66,105
 
8/3/2007
 
100
66,005
 
8/3/2007
 
500
65,505
 
8/3/2007
 
500
65,005
 
8/3/2007
 
100
64,905
 
8/3/2007
 
465
64,440
 
8/3/2007
 
150
64,290
 
8/3/2007
 
500
63,790
 
8/3/2007
 
100
63,690
 
8/3/2007
 
100
63,590
 
8/3/2007
 
85
63,505
 
8/3/2007
2,500
 
66,005
 
8/3/2007
2,500
 
68,505
 
8/3/2007
100
 
68,605
 
8/3/2007
300
 
68,905
 
8/3/2007
100
 
69,005
 
8/3/2007
2,000
 
71,005
 
8/3/2007
500
 
71,505
 
8/3/2007
100
 
71,605
 
8/3/2007
400
 
72,005
 
8/6/2007
1,000
 
73,005
 
8/6/2007
1,000
 
74,005
 
8/6/2007
 
1,000
73,005
 
8/6/2007
150
 
73,155
 
8/6/2007
100
 
73,255
 
8/7/2007
500
 
73,755
 
8/7/2007
 
1,100
72,655
 
8/7/2007
 
4,000
68,655
 
8/7/2007
 
100
68,555
 
8/7/2007
488
 
69,043

 
53

 


 
8/7/2007
500
 
69,543
 
8/7/2007
300
 
69,843
 
8/7/2007
200
 
70,043
 
8/7/2007
2,000
 
72,043
 
8/7/2007
55
 
72,098
 
8/7/2007
45
 
72,143
 
8/7/2007
100
 
72,243
 
8/7/2007
100
 
72,343
 
8/7/2007
100
 
72,443
 
8/7/2007
100
 
72,543
 
8/7/2007
500
 
73,043
 
8/7/2007
81
 
73,124
 
8/7/2007
100
 
73,224
 
8/7/2007
100
 
73,324
 
8/7/2007
2,219
 
75,543
 
8/7/2007
1,500
 
77,043
 
8/7/2007
100
 
77,143
 
8/7/2007
200
 
77,343
 
8/7/2007
100
 
77,443
 
8/7/2007
250
 
77,693
 
8/8/2008
 
1,000
76,693
 
8/8/2008
 
1,000
75,693
 
8/8/2008
 
100
75,593
 
8/8/2008
 
1,900
73,693
 
8/8/2008
500
 
74,193
 
8/8/2008
500
 
74,693
 
8/8/2008
250
 
74,943
 
8/9/2007
250
 
75,193
 
8/9/2007
237
 
75,430
 
8/13/2007
 
1,288
74,142
 
8/13/2007
 
700
73,442
 
8/13/2007
 
300
73,142
 
8/13/2007
 
937
72,205
 
8/13/2007
 
1,300
70,905
 
8/13/2007
 
100
70,805
 
8/13/2007
 
400
70,405
 
8/13/2007
500
 
70,905
 
8/13/2007
500
 
71,405
 
8/13/2007
1,500
 
72,905
 
8/13/2007
200
 
73,105
 
8/13/2007
200
 
73,305
 
8/14/2007
100
 
73,405
 
8/14/2007
300
 
73,705
 
8/14/2007
200
 
73,905
 
8/14/2007
100
 
74,005
 
8/14/2007
100
 
74,105
 
8/14/2007
100
 
74,205
 
8/14/2007
100
 
74,305
 
8/14/2007
100
 
74,405

 
54

 


 
8/14/2007
500
 
74,905
 
8/15/2007
500
 
75,405
 
8/16/2007
1,000
 
76,405
 
8/16/2007
1,000
 
77,405
 
8/16/2007
300
 
77,705
 
8/16/2007
200
 
77,905
 
8/16/2007
 
700
77,205
 
8/16/2007
 
200
77,005
 
8/16/2007
 
100
76,905
 
8/16/2007
 
300
76,605
 
8/17/2007
200
 
76,805
 
8/17/2007
300
 
77,105
 
8/17/2007
500
 
77,605
 
8/17/2007
1,500
 
79,105
 
8/17/2007
 
2,000
77,105
 
8/17/2007
300
 
77,405
 
8/17/2007
200
 
77,605
 
8/20/2007
2,000
 
79,605
 
8/20/2007
3,000
 
82,605
 
8/20/2007
2,100
 
84,705
 
8/20/2007
400
 
85,105
 
8/20/2007
1,500
 
86,605
 
8/20/2007
200
 
86,805
 
8/20/2007
300
 
87,105
 
8/20/2007
200
 
87,305
 
8/20/2007
200
 
87,505
 
8/21/2007
1,000
 
88,505
 
8/21/2007
1,000
 
89,505
 
8/22/2007
500
 
90,005
 
8/23/2007
1,500
 
91,505
 
8/23/2007
600
 
92,105
 
8/23/2007
600
 
92,705
 
8/24/2007
 
5,000
87,705
 
8/24/2007
 
5,000
82,705
 
8/27/2008
 
600
82,105
 
8/27/2008
 
300
81,805
 
8/27/2008
 
4,000
77,805
 
8/27/2008
 
2,100
75,705
 
8/27/2008
 
50
75,655
 
8/27/2008
 
3,850
71,805
 
8/27/2008
 
100
71,705
 
8/27/2008
 
100
71,605
 
8/27/2008
 
100
71,505
 
8/27/2008
 
190
71,315
 
8/27/2008
 
100
71,215
 
8/27/2008
 
100
71,115
 
8/27/2008
 
6,000
65,115
 
8/27/2008
 
100
65,015
 
8/27/2008
 
2,910
62,105

 
55

 


 
8/27/2008
1,000
 
63,105
 
8/27/2008
300
 
63,405
 
8/27/2008
200
 
63,605
 
8/27/2008
300
 
63,905
 
8/28/2007
 
1,654
62,251
 
8/28/2007
 
846
61,405
 
8/28/2007
 
500
60,905
 
8/28/2007
 
200
60,705
 
8/28/2007
 
3,100
57,605
 
8/28/2007
 
100
57,505
 
8/28/2007
 
100
57,405
 
8/30/2007
200
 
57,605
 
8/30/2007
100
 
57,705
 
8/30/2007
2,145
 
59,850
 
8/30/2007
2,555
 
62,405
 
8/30/2007
500
 
62,905
 
8/30/2007
2,445
 
65,350
 
8/30/2007
955
 
66,305
 
8/30/2007
100
 
66,405
 
8/30/2007
2,500
 
68,905
 
8/30/2007
700
 
69,605
 
8/30/2007
1,800
 
71,405
 
8/30/2007
 
5,000
66,405
 
8/30/2007
2,000
 
68,405
 
8/30/2007
 
200
68,205
 
8/30/2007
1,100
 
69,305
 
8/30/2007
300
 
69,605
 
8/30/2007
 
100
69,505
 
8/30/2007
 
900
68,605
 
8/30/2007
 
100
68,505
 
8/30/2007
 
406
68,099
 
9/4/2007
 
5,000
63,099
 
9/4/2007
 
2,500
60,599
 
9/4/2007
 
2,500
58,099
 
9/4/2007
 
2,500
55,599
 
9/4/2007
 
1,200
54,399
 
9/5/2007
10,000
 
64,399
 
9/5/2007
3,000
 
67,399
 
9/5/2007
300
 
67,699
 
9/5/2007
3,200
 
70,899
 
9/5/2007
1,290
 
72,189
 
9/5/2007
 
894
71,295
 
9/5/2007
200
 
71,495
 
9/7/2007
1,500
 
72,995
 
9/7/2007
 
1,200
71,795
 
9/7/2007
 
700
71,095
 
9/7/2007
 
100
70,995
 
9/7/2007
 
200
70,795
 
9/7/2007
 
1,500
69,295

 
56

 


 
9/10/2007
 
1,000
68,295
 
9/10/2007
 
11,000
57,295
 
9/10/2007
 
2,000
55,295
 
9/10/2007
 
1,000
54,295
 
9/10/2007
 
600
53,695
 
9/10/2007
 
1,200
52,495
 
9/10/2007
 
200
52,295
 
9/10/2007
 
905
51,390
 
9/10/2007
4,000
 
55,390
 
9/10/2007
5,000
 
60,390
 
9/10/2007
2,500
 
62,890
 
9/10/2007
200
 
63,090
 
9/10/2007
100
 
63,190
 
9/11/2007
5,000
 
68,190
 
9/11/2007
500
 
68,690
 
9/11/2007
1,500
 
70,190
 
9/11/2007
200
 
70,390
 
9/11/2007
400
 
70,790
 
9/11/2007
500
 
71,290
 
9/12/2007
1,500
 
72,790
 
9/13/2007
500
 
73,290
 
9/13/2007
1,000
 
74,290
 
9/13/2007
 
200
74,090
 
9/13/2007
 
100
73,990
 
9/13/2007
 
100
73,890
 
9/13/2007
 
100
73,790
 
9/13/2007
 
200
73,590
 
9/13/2007
 
100
73,490
 
9/13/2007
 
373
73,117
 
9/13/2007
 
127
72,990
 
9/14/2007
1,000
 
73,990
 
9/14/2007
 
500
73,490
 
9/14/2007
 
100
73,390
 
9/14/2007
 
100
73,290
 
9/14/2007
 
100
73,190
 
9/14/2007
200
 
73,390
 
9/14/2007
100
 
73,490
 
9/14/2007
800
 
74,290
 
9/14/2007
100
 
74,390
 
9/17/2007
 
1,000
73,390
 
9/17/2007
 
5,000
68,390
 
9/17/2007
 
1,295
67,095
 
9/17/2007
 
2,000
65,095
 
9/17/2007
 
1,200
63,895
 
9/17/2007
 
1,400
62,495
 
9/17/2007
200
 
62,695
 
9/18/2007
 
6,390
56,305
 
9/18/2007
 
100
56,205
 
9/18/2007
 
200
56,005

 
57

 


 
9/18/2007
 
100
55,905
 
9/18/2007
 
400
55,505
 
9/18/2007
500
 
56,005
 
9/18/2007
200
 
56,205
 
9/18/2007
100
 
56,305
 
9/18/2007
100
 
56,405
 
9/18/2007
200
 
56,605
 
9/18/2007
100
 
56,705
 
9/19/2007
1,000
 
57,705
 
9/19/2007
1,000
 
58,705
 
9/19/2007
400
 
59,105
 
9/19/2007
1,600
 
60,705
 
9/19/2007
2,000
 
62,705
 
9/19/2007
400
 
63,105
 
9/19/2007
300
 
63,405
 
9/20/2007
 
4,400
59,005
 
9/20/2007
1,500
 
60,505
 
9/24/2007
1,000
 
61,505
 
9/24/2007
500
 
62,005
 
9/24/2007
500
 
62,505
 
9/24/2007
2,000
 
64,505
 
9/24/2007
 
5,200
59,305
 
9/24/2007
 
400
58,905
 
9/24/2007
 
100
58,805
 
9/24/2007
 
100
58,705
 
9/24/2007
 
5,200
53,505
 
9/24/2007
 
2,600
50,905
 
9/24/2007
 
1,000
49,905
 
9/24/2007
 
361
49,544
 
9/24/2007
 
100
49,444
 
9/24/2007
 
939
48,505
 
9/24/2007
2,500
 
51,005
 
9/24/2007
2,500
 
53,505
 
9/25/2007
 
1,500
52,005
 
9/25/2007
1,000
 
53,005
 
9/25/2007
600
 
53,605
 
9/25/2007
100
 
53,705
 
9/25/2007
100
 
53,805
 
9/25/2007
100
 
53,905
 
9/25/2007
100
 
54,005
 
9/27/2007
 
1,500
52,505
 
9/27/2007
 
2,120
50,385
 
9/27/2007
 
100
50,285
 
9/27/2007
 
100
50,185
 
10/1/2007
 
980
49,205
 
10/1/2007
 
1,380
47,825
 
10/2/2007
 
1,500
46,325
 
10/2/2007
 
295
46,030
 
10/2/2007
 
1,000
45,030

 
58

 


 
10/2/2007
 
3,000
42,030
 
10/2/2007
 
100
41,930
 
10/2/2007
 
1,400
40,530
 
10/2/2007
 
300
40,230
 
10/2/2007
 
8,905
31,325
 
10/3/2007
1,000
 
32,325
 
10/3/2007
5,000
 
37,325
 
10/4/2007
 
700
36,625
 
10/8/2007
 
1,500
35,125
 
10/11/2007
800
 
35,925
 
10/11/2007
1,000
 
36,925
 
10/11/2007
300
 
37,225
 
10/11/2007
200
 
37,425
 
10/11/2007
133
 
37,558
 
10/11/2007
100
 
37,658
 
10/11/2007
100
 
37,758
 
10/11/2007
200
 
37,958
 
10/11/2007
100
 
38,058
 
10/11/2007
367
 
38,425
 
10/11/2007
200
 
38,625
 
10/11/2007
100
 
38,725
 
10/11/2007
200
 
38,925
 
10/11/2007
200
 
39,125
 
10/11/2007
200
 
39,325
 
10/11/2007
200
 
39,525
 
10/11/2007
200
 
39,725
 
10/11/2007
200
 
39,925
 
10/11/2007
100
 
40,025
 
10/11/2007
200
 
40,225
 
10/11/2007
200
 
40,425
 
10/11/2007
200
 
40,625
 
10/11/2007
100
 
40,725
 
10/11/2007
100
 
40,825
 
10/11/2007
1,500
 
42,325
 
10/11/2007
100
 
42,425
 
10/12/2007
 
3,320
39,105
 
10/12/2007
 
200
38,905
 
10/12/2007
 
100
38,805
 
10/12/2007
 
3,900
34,905
 
10/12/2007
 
1,100
33,805
 
10/17/2007
 
1,000
32,805
 
10/17/2007
 
1,200
31,605
 
10/17/2007
 
100
31,505
 
10/17/2007
 
900
30,605
 
10/17/2007
 
100
30,505
 
10/17/2007
 
200
30,305
 
10/17/2007
 
200
30,105
 
10/17/2007
 
300
29,805
 
10/17/2007
 
100
29,705

 
59

 


 
10/17/2007
 
100
29,605
 
10/18/2007
 
300
29,305
 
10/22/2007
1,000
 
30,305
 
10/22/2007
500
 
30,805
 
10/22/2007
500
 
31,305
 
10/22/2007
1,000
 
32,305
 
10/25/2007
 
1,000
31,305
 
10/25/2007
 
500
30,805
 
10/25/2007
 
500
30,305
 
10/25/2007
 
500
29,805
 
10/25/2007
 
1,000
28,805
 
10/25/2007
 
1,000
27,805
 
10/25/2007
 
1,000
26,805
 
10/26/2007
1,000
 
27,805
 
10/30/2007
 
600
27,205
 
10/30/2007
 
400
26,805
 
10/30/2007
 
100
26,705
 
10/30/2007
 
900
25,805
 
11/13/2007
500
 
26,305
 
11/14/2007
300
 
26,605
 
11/14/2007
1,200
 
27,805
 
11/14/2007
200
 
28,005
 
11/14/2007
100
 
28,105
 
11/14/2007
100
 
28,205
 
11/14/2007
100
 
28,305
 
11/14/2007
500
 
28,805
 
11/19/2007
100
 
28,905
 
11/19/2007
100
 
29,005
 
11/19/2007
100
 
29,105
 
11/19/2007
100
 
29,205
 
11/19/2007
2,600
 
31,805
 
11/19/2007
100
 
31,905
 
11/19/2007
400
 
32,305
 
11/19/2007
100
 
32,405
 
11/19/2007
49
 
32,454
 
11/19/2007
2,351
 
34,805
 
11/19/2007
100
 
34,905
 
11/19/2007
100
 
35,005
 
11/19/2007
300
 
35,305
 
11/19/2007
100
 
35,405
 
11/19/2007
100
 
35,505
 
11/19/2007
270
 
35,775
 
11/19/2007
200
 
35,975
 
11/19/2007
100
 
36,075
 
11/19/2007
100
 
36,175
 
11/19/2007
100
 
36,275
 
11/19/2007
30
 
36,305
 
11/19/2007
400
 
36,705
 
11/19/2007
600
 
37,305

 
60

 


 
11/19/2007
100
 
37,405
 
11/19/2007
400
 
37,805
 
11/20/2007
 
100
37,705
 
11/20/2007
 
100
37,605
 
11/20/2007
 
200
37,405
 
11/20/2007
 
100
37,305
 
11/20/2007
 
90
37,215
 
11/20/2007
 
100
37,115
 
11/20/2007
 
45
37,070
 
11/20/2007
 
100
36,970
 
11/20/2007
 
10
36,960
 
11/20/2007
 
100
36,860
 
11/20/2007
 
55
36,805
 
11/20/2007
 
1,000
35,805
 
11/21/2007
 
200
35,605
 
11/21/2007
 
100
35,505
 
11/21/2007
 
1,700
33,805
 
11/21/2007
 
300
33,505
 
11/21/2007
 
100
33,405
 
11/21/2007
 
600
32,805
 
11/21/2007
1,000
 
33,805
 
11/21/2007
100
 
33,905
 
11/21/2007
900
 
34,805
 
11/21/2007
1,000
 
35,805
 
11/21/2007
300
 
36,105
 
11/21/2007
1,700
 
37,805
 
11/23/2007
 
100
37,705
 
11/23/2007
 
100
37,605
 
11/23/2007
 
190
37,415
 
11/23/2007
100
 
37,515
 
11/23/2007
100
 
37,615
 
11/23/2007
300
 
37,915
 
11/23/2007
350
 
38,265
 
11/26/2007
 
2,460
35,805
 
11/27/2007
 
1,000
34,805
 
11/27/2007
 
2,000
32,805
 
11/27/2007
 
900
31,905
 
11/27/2007
 
389
31,516
 
11/27/2007
 
100
31,416
 
11/27/2007
 
100
31,316
 
12/3/2007
 
2,511
28,805
 
12/3/2007
500
 
29,305
 
12/3/2007
1,000
 
30,305
 
12/3/2007
200
 
30,505
 
12/3/2007
300
 
30,805
 
12/3/2007
500
 
31,305
 
12/3/2007
500
 
31,805
 
12/3/2007
500
 
32,305
 
12/3/2007
700
 
33,005

 
61

 


 
12/3/2007
300
 
33,305
 
12/3/2007
75
 
33,380
 
12/3/2007
400
 
33,780
 
12/3/2007
500
 
34,280
 
12/3/2007
525
 
34,805
 
12/3/2007
25
 
34,830
 
12/3/2007
475
 
35,305
 
12/3/2007
300
 
35,605
 
12/3/2007
200
 
35,805
 
12/3/2007
1,000
 
36,805
 
12/4/2007
 
1,500
35,305
 
12/4/2007
 
1,000
34,305
 
12/4/2007
 
2,500
31,805
 
12/4/2007
 
100
31,705
 
12/4/2007
 
3,700
28,005
 
12/4/2007
 
100
27,905
 
12/4/2007
 
1,100
26,805
 
12/4/2007
 
200
26,605
 
12/4/2007
 
2,114
24,491
 
12/4/2007
 
2,886
21,605
 
12/4/2007
1,300
 
22,905
 
12/4/2007
1,000
 
23,905
 
12/4/2007
257
 
24,162
 
12/4/2007
1,400
 
25,562
 
12/4/2007
100
 
25,662
 
12/4/2007
100
 
25,762
 
12/4/2007
100
 
25,862
 
12/4/2007
100
 
25,962
 
12/4/2007
1,700
 
27,662
 
12/4/2007
500
 
28,162
 
12/4/2007
200
 
28,362
 
12/4/2007
43
 
28,405
 
12/4/2007
2,000
 
30,405
 
12/4/2007
400
 
30,805
 
12/4/2007
400
 
31,205
 
12/4/2007
100
 
31,305
 
12/7/2007
 
1,000
30,305
 
12/10/2007
1,000
 
31,305
 
12/10/2007
300
 
31,605
 
12/10/2007
100
 
31,705
 
12/10/2007
500
 
32,205
 
12/10/2007
200
 
32,405
 
12/10/2007
300
 
32,705
 
12/10/2007
1,100
 
33,805
 
12/13/2007
 
900
32,905
 
12/13/2007
 
100
32,805
 
12/13/2007
 
590
32,215
 
12/13/2007
 
100
32,115
 
12/13/2007
 
500
31,615

 
62

 


 
12/13/2007
 
100
31,515
 
12/13/2007
 
100
31,415
 
12/13/2007
 
100
31,315
 
12/13/2007
 
100
31,215
 
12/17/2007
500
 
31,715
 
12/17/2007
400
 
32,115
 
12/17/2007
600
 
32,715
 
12/20/2007
 
1,172
31,543
 
12/20/2007
900
 
32,443
 
12/20/2007
362
 
32,805
 
12/27/2007
 
1,000
31,805
 
1/3/2008
 
300
31,505
 
1/3/2008
 
100
31,405
 
1/3/2008
 
100
31,305
 
1/3/2008
 
100
31,205
 
1/7/2008
 
100
31,105
 
1/7/2008
 
100
31,005
 
1/7/2008
 
100
30,905
 
1/7/2008
 
100
30,805
 
1/9/2008
 
100
30,705
 
1/9/2008
 
400
30,305
 
1/11/2008
 
500
29,805
 
1/11/2008
 
700
29,105
 
1/11/2008
 
300
28,805
 
1/11/2008
100
 
28,905
 
1/11/2008
400
 
29,305
 
1/14/2008
 
1,000
28,305
 
1/14/2008
 
500
27,805
 
1/14/2008
 
100
27,705
 
1/14/2008
 
100
27,605
 
1/14/2008
 
100
27,505
 
1/14/2008
 
100
27,405
 
1/15/2008
300
 
27,705
 
1/15/2008
1,000
 
28,705
 
1/15/2008
500
 
29,205
 
1/15/2008
100
 
29,305
 
1/15/2008
100
 
29,405
 
1/15/2008
100
 
29,505
 
1/15/2008
200
 
29,705
 
1/15/2008
200
 
29,905
 
1/15/2008
300
 
30,205
 
1/16/2008
100
 
30,305
 
1/16/2008
150
 
30,455
 
1/16/2008
100
 
30,555
 
1/16/2008
100
 
30,655
 
1/16/2008
50
 
30,705
 
1/17/2008
 
1,400
29,305
 
1/18/2008
500
 
29,805
 
1/22/2008
600
 
30,405

 
63

 


 
1/24/2008
18
 
30,423
 
1/24/2008
100
 
30,523
 
1/24/2008
332
 
30,855
 
2/11/2008
1,500
 
32,355
 
2/11/2008
500
 
32,855
 
2/11/2008
3,000
 
35,855
 
2/11/2008
1,000
 
36,855
 
2/11/2008
2,000
 
38,855
 
2/11/2008
1,900
 
40,755
 
2/11/2008
100
 
40,855
 
2/11/2008
1,900
 
42,755
 
2/11/2008
600
 
43,355
 
2/12/2008
 
3,000
40,355
 
2/13/2008
1,500
 
41,855
 
2/13/2008
1,000
 
42,855
 
2/13/2008
950
 
43,805
 
2/13/2008
450
 
44,255
 
2/15/2008
 
1,000
43,255
 
2/15/2008
100
 
43,355
 
2/15/2008
900
 
44,255
 
2/15/2008
1,000
 
45,255
 
2/15/2008
 
500
44,755
 
2/15/2008
 
400
44,355
 
2/15/2008
 
50
44,305
 
2/15/2008
300
 
44,605
 
2/15/2008
300
 
44,905
 
2/19/2008
 
100
44,805
 
2/19/2008
300
 
45,105
 
2/21/2008
125
 
45,230
 
2/27/2008
 
1,200
44,030
 
2/27/2008
1,000
 
45,030
 
2/27/2008
300
 
45,330
 
2/27/2008
1,200
 
46,530
 
2/27/2008
200
 
46,730
 
2/27/2008
100
 
46,830
 
2/27/2008
100
 
46,930
 
2/27/2008
1,400
 
48,330
 
2/27/2008
700
 
49,030
 
2/27/2008
575
 
49,605
 
2/27/2008
250
 
49,855
 
2/27/2008
250
 
50,105
 
2/28/2008
400
 
50,505
 
2/28/2008
800
 
51,305
 
2/29/2008
1,000
 
52,305
 
2/29/2008
2,000
 
54,305
 
2/29/2008
200
 
54,505
 
2/29/2008
100
 
54,605
 
2/29/2008
133
 
54,738
 
2/29/2008
100
 
54,838

 
64

 


 
2/29/2008
200
 
55,038
 
2/29/2008
200
 
55,238
 
2/29/2008
200
 
55,438
 
2/29/2008
133
 
55,571
 
2/29/2008
178
 
55,749
 
2/29/2008
118
 
55,867
 
2/29/2008
200
 
56,067
 
2/29/2008
38
 
56,105
 
2/29/2008
500
 
56,605
 
2/29/2008
1,000
 
57,605
 
2/29/2008
700
 
58,305
 
2/29/2008
1,700
 
60,005
 
2/29/2008
1,300
 
61,305
 
3/3/2008
 
100
61,205
 
3/3/2008
 
900
60,305
 
3/3/2008
 
100
60,205
 
3/3/2008
 
199
60,006
 
3/3/2008
 
100
59,906
 
3/3/2008
 
1,101
58,805
 
3/3/2008
 
100
58,705
 
3/3/2008
 
100
58,605
 
3/3/2008
 
499
58,106
 
3/3/2008
200
 
58,306
 
3/3/2008
100
 
58,406
 
3/3/2008
35
 
58,441
 
3/3/2008
915
 
59,356
 
3/6/2008
700
 
60,056
 
3/10/2008
 
3,700
56,356
 
3/12/2008
 
1,700
54,656
 
3/12/2008
949
 
55,605
 
3/13/2008
1,700
 
57,305
 
3/14/2008
212
 
57,517
 
3/14/2008
788
 
58,305
 
3/14/2008
1,000
 
59,305
 
3/14/2008
200
 
59,505
 
3/14/2008
500
 
60,005
 
3/19/2008
100
 
60,105
 
3/19/2008
500
 
60,605
 
3/19/2008
2,400
 
63,005
 
3/19/2008
300
 
63,305
 
3/19/2008
100
 
63,405
 
3/19/2008
200
 
63,605
 
3/19/2008
100
 
63,705
 
3/19/2008
100
 
63,805
 
3/19/2008
800
 
64,605
 
3/19/2008
85
 
64,690
 
3/19/2008
1,015
 
65,705
 
3/19/2008
400
 
66,105
 
3/19/2008
2,500
 
68,605

 
65

 


 
3/19/2008
600
 
69,205
 
3/19/2008
400
 
69,605
 
3/19/2008
100
 
69,705
 
3/19/2008
100
 
69,805
 
3/19/2008
400
 
70,205
 
3/19/2008
100
 
70,305
 
3/19/2008
900
 
71,205
 
3/24/2008
600
 
71,805
 
3/24/2008
100
 
71,905
 
3/24/2008
1,300
 
73,205
 
3/24/2008
1,050
 
74,255
 
3/24/2008
200
 
74,455
 
3/25/2008
200
 
74,655
 
3/25/2008
300
 
74,955
 
3/25/2008
500
 
75,455
 
3/25/2008
500
 
75,955
 
3/25/2008
500
 
76,455
 
3/25/2008
100
 
76,555
 
3/25/2008
400
 
76,955
 
3/25/2008
500
 
77,455
 
3/25/2008
100
 
77,555
 
3/25/2008
100
 
77,655
 
3/25/2008
100
 
77,755
 
3/25/2008
200
 
77,955
 
3/25/2008
100
 
78,055
 
3/25/2008
400
 
78,455
 
3/25/2008
350
 
78,805
 
3/25/2008
900
 
79,705
 
3/25/2008
1,200
 
80,905
 
3/25/2008
200
 
81,105
 
3/25/2008
100
 
81,205
 
3/25/2008
5,000
 
86,205
 
3/25/2008
1,000
 
87,205
 
3/26/2008
1,000
 
88,205
 
3/26/2008
1,000
 
89,205
 
3/26/2008
1,000
 
90,205
 
3/26/2008
1,000
 
91,205
 
3/26/2008
300
 
91,505
 
3/26/2008
700
 
92,205
 
3/26/2008
100
 
92,305
 
3/26/2008
100
 
92,405
 
3/26/2008
100
 
92,505
 
3/26/2008
100
 
92,605
 
3/26/2008
100
 
92,705
 
3/26/2008
100
 
92,805
 
3/26/2008
300
 
93,105
 
3/26/2008
1,000
 
94,105
 
3/26/2008
1,000
 
95,105
 
3/26/2008
1,000
 
96,105

 
66

 


 
3/26/2008
100
 
96,205
 
3/27/2008
 
300
95,905
 
3/27/2008
 
500
95,405
 
3/27/2008
2,500
 
97,905
 
3/27/2008
3,000
 
100,905
 
3/27/2008
3,000
 
103,905
 
3/27/2008
100
 
104,005
 
3/27/2008
900
 
104,905
 
3/28/2008
 
300
104,605
 
3/28/2008
 
1,900
102,705
 
3/28/2008
 
100
102,605
 
3/28/2008
 
575
102,030
 
3/28/2008
 
100
101,930
 
3/28/2008
 
500
101,430
 
3/28/2008
 
500
100,930
 
3/28/2008
 
2,200
98,730
 
3/28/2008
 
800
97,930
 
3/28/2008
 
200
97,730
 
3/28/2008
 
100
97,630
 
3/28/2008
 
100
97,530
 
3/28/2008
 
100
97,430
 
3/28/2008
 
100
97,330
 
3/28/2008
 
425
96,905
 
3/28/2008
 
100
96,805
 
3/28/2008
 
100
96,705
 
3/28/2008
 
100
96,605
 
3/28/2008
 
100
96,505
 
3/28/2008
 
100
96,405
 
3/28/2008
 
100
96,305
 
3/28/2008
 
200
96,105
 
3/28/2008
 
200
95,905
 
3/28/2008
 
100
95,805
 
3/28/2008
 
200
95,605
 
3/28/2008
 
300
95,305
 
3/28/2008
 
900
94,405
 
3/28/2008
1,040
 
95,445
 
3/28/2008
235
 
95,680
 
3/31/2008
2,500
 
98,180
 
3/31/2008
2,000
 
100,180
 
3/31/2008
3,000
 
103,180
 
3/31/2008
1,525
 
104,705
 
4/1/2008
1,500
 
106,205
 
4/1/2008
2,000
 
108,205
 
4/1/2008
1,000
 
109,205
 
4/3/2008
 
4,500
104,705
 
4/4/2008
 
200
104,505
 
4/4/2008
 
209
104,296
 
4/4/2008
 
200
104,096
 
4/4/2008
 
400
103,696

 
67

 


 
4/4/2008
 
100
103,596
 
4/4/2008
 
100
103,496
 
4/4/2008
200
 
103,696
 
4/4/2008
399
 
104,095
 
4/4/2008
500
 
104,595
 
4/4/2008
100
 
104,695
 
4/4/2008
500
 
105,195
 
4/4/2008
500
 
105,695
 
4/4/2008
500
 
106,195
 
4/4/2008
100
 
106,295
 
4/4/2008
100
 
106,395
 
4/4/2008
100
 
106,495
 
4/4/2008
200
 
106,695
 
4/4/2008
200
 
106,895
 
4/7/2008
100
 
106,995
 
4/7/2008
100
 
107,095
 
4/7/2008
100
 
107,195
 
4/7/2008
300
 
107,495
 
4/7/2008
500
 
107,995
 
4/7/2008
300
 
108,295
 
4/7/2008
610
 
108,905
 
4/7/2008
250
 
109,155
 
4/11/2008
 
2,000
107,155
 
4/11/2008
 
1,000
106,155
 
4/11/2008
 
100
106,055
 
4/11/2008
 
200
105,855
 
4/11/2008
 
300
105,555
 
4/11/2008
 
5,900
99,655
 
4/11/2008
 
100
99,555
 
4/11/2008
100
 
99,655
 
4/11/2008
200
 
99,855
 
4/11/2008
100
 
99,955
 
4/14/2008
1,450
 
101,405
 
4/14/2008
1,500
 
102,905
 
4/14/2008
1,500
 
104,405
 
4/15/2008
500
 
104,905
 
4/15/2008
100
 
105,005
 
4/15/2008
100
 
105,105
 
4/15/2008
100
 
105,205
 
4/15/2008
100
 
105,305
 
4/15/2008
100
 
105,405
 
4/15/2008
100
 
105,505
 
4/15/2008
100
 
105,605
 
4/15/2008
100
 
105,705
 
4/15/2008
100
 
105,805
 
4/15/2008
100
 
105,905
 
4/15/2008
625
 
106,530
 
4/15/2008
75
 
106,605
 
4/15/2008
800
 
107,405

 
68

 


 
4/15/2008
1,500
 
108,905
 
4/15/2008
500
 
109,405
 
4/15/2008
250
 
109,655
 
4/15/2008
100
 
109,755
 
4/15/2008
100
 
109,855
 
4/15/2008
1,050
 
110,905
 
4/16/2008
1,500
 
112,405
 
4/16/2008
500
 
112,905
 
4/16/2008
500
 
113,405
 
4/16/2008
100
 
113,505
 
4/16/2008
100
 
113,605
 
4/16/2008
100
 
113,705
 
4/16/2008
100
 
113,805
 
4/16/2008
100
 
113,905
 
4/16/2008
100
 
114,005
 
4/16/2008
100
 
114,105
 
4/16/2008
500
 
114,605
 
4/16/2008
500
 
115,105
 
4/18/2008
1,750
 
116,855
 
4/18/2008
100
 
116,955
 
4/18/2008
1,600
 
118,555
 
4/18/2008
1,400
 
119,955
 
4/18/2008
1,000
 
120,955
 
4/18/2008
1,000
 
121,955
 
4/18/2008
2,500
 
124,455
 
4/18/2008
2,500
 
126,955
 
4/18/2008
500
 
127,455
 
4/24/2008
 
1,668
125,787
 
4/25/2008
 
2,000
123,787
 
4/25/2008
300
 
124,087
 
4/28/2008
 
700
123,387
 
4/28/2008
 
600
122,787
 
4/28/2008
 
182
122,605
 
4/28/2008
 
200
122,405
 
4/28/2008
 
300
122,105
 
4/28/2008
 
100
122,005
 
4/28/2008
 
700
121,305
 
4/28/2008
 
200
121,105
 
4/28/2008
 
100
121,005
 
4/28/2008
 
200
120,805
 
4/28/2008
 
200
120,605
 
4/28/2008
 
100
120,505
 
4/28/2008
 
100
120,405
 
4/28/2008
 
200
120,205
 
4/28/2008
 
100
120,105
 
4/28/2008
 
100
120,005
 
4/28/2008
 
500
119,505
 
4/28/2008
 
600
118,905
 
4/28/2008
 
500
118,405

 
69

 


 
4/28/2008
 
800
117,605
 
4/28/2008
 
100
117,505
 
4/28/2008
 
1,200
116,305
 
4/28/2008
 
100
116,205
 
4/28/2008
 
100
116,105
 
4/28/2008
 
500
115,605
 
4/28/2008
 
200
115,405
 
4/28/2008
 
100
115,305
 
4/28/2008
 
100
115,205
 
4/28/2008
2,500
 
117,705
 
4/28/2008
500
 
118,205
 
4/28/2008
500
 
118,705
 
4/28/2008
300
 
119,005
 
4/29/2008
 
10,000
109,005
 
4/29/2008
 
1,068
107,937
 
4/29/2008
 
500
107,437
 
4/29/2008
 
100
107,337
 
4/29/2008
 
200
107,137
 
4/29/2008
 
200
106,937
 
4/29/2008
 
332
106,605
 
4/29/2008
 
100
106,505
 
4/29/2008
282
 
106,787
 
4/29/2008
2,500
 
109,287
 
4/29/2008
1,500
 
110,787
 
4/29/2008
500
 
111,287
 
4/29/2008
500
 
111,787
 
4/29/2008
500
 
112,287
 
4/29/2008
500
 
112,787
 
4/29/2008
500
 
113,287
 
4/29/2008
100
 
113,387
 
4/29/2008
100
 
113,487
 
4/29/2008
100
 
113,587
 
4/29/2008
400
 
113,987
 
4/29/2008
2,000
 
115,987
 
4/30/2008
 
1,000
114,987
 
4/30/2008
 
24,000
90,987
 
4/30/2008
300
 
91,287
 
4/30/2008
300
 
91,587
 
4/30/2008
300
 
91,887
 
4/30/2008
200
 
92,087
 
4/30/2008
100
 
92,187
 
5/2/2008
 
100
92,087
 
5/2/2008
 
100
91,987
 
5/2/2008
 
200
91,787
 
5/2/2008
 
100
91,687
 
5/2/2008
 
200
91,487
 
5/2/2008
 
100
91,387
 
5/2/2008
 
113
91,274
 
5/2/2008
 
100
91,174

 
70

 


 
5/2/2008
 
100
91,074
 
5/2/2008
 
87
90,987
 
5/5/2008
300
 
91,287
 
5/5/2008
100
 
91,387
 
5/9/2008
1,818
 
93,205
 
5/9/2008
100
 
93,305
 
5/9/2008
500
 
93,805
 
5/9/2008
500
 
94,305
 
5/9/2008
100
 
94,405
 
5/9/2008
400
 
94,805
 
5/9/2008
2,200
 
97,005
 
5/9/2008
300
 
97,305
 
5/9/2008
500
 
97,805
 
5/9/2008
1,400
 
99,205
 
5/9/2008
1,100
 
100,305
 
5/16/2008
 
7,900
92,405
 
5/16/2008
 
1,500
90,905
 
5/16/2008
 
7,600
83,305
 
5/16/2008
 
3,000
80,305
 
5/16/2008
 
400
79,905
 
5/16/2008
 
4,600
75,305
 
5/16/2008
 
126
75,179
 
5/16/2008
1,800
 
76,979
 
5/16/2008
826
 
77,805
 
5/16/2008
100
 
77,905
 
5/16/2008
600
 
78,505
 
5/16/2008
600
 
79,105
 
5/16/2008
3,300
 
82,405
 
5/16/2008
400
 
82,805
 
5/16/2008
100
 
82,905
 
5/16/2008
100
 
83,005
 
5/16/2008
100
 
83,105
 
5/16/2008
100
 
83,205
 
5/16/2008
100
 
83,305
 
5/16/2008
100
 
83,405
 
5/16/2008
100
 
83,505
 
5/16/2008
300
 
83,805
 
5/16/2008
100
 
83,905
 
5/16/2008
100
 
84,005
 
5/16/2008
100
 
84,105
 
5/16/2008
100
 
84,205
 
5/16/2008
100
 
84,305
 
5/16/2008
100
 
84,405
 
5/16/2008
100
 
84,505
 
5/16/2008
100
 
84,605
 
5/16/2008
100
 
84,705
 
5/16/2008
100
 
84,805
 
5/16/2008
100
 
84,905
 
5/16/2008
400
 
85,305

 
71

 


 
5/16/2008
200
 
85,505
 
5/19/2008
2,500
 
88,005
 
5/19/2008
2,300
 
90,305
 
5/19/2008
400
 
90,705
 
5/19/2008
400
 
91,105
 
5/19/2008
100
 
91,205
 
5/19/2008
500
 
91,705
 
5/19/2008
1,100
 
92,805
 
5/19/2008
1,500
 
94,305
 
5/19/2008
2,500
 
96,805
 
5/20/2008
2,000
 
98,805
 
5/20/2008
 
100
98,705
 
5/20/2008
 
100
98,605
 
5/20/2008
 
100
98,505
 
5/20/2008
 
100
98,405
 
5/20/2008
 
100
98,305
 
5/20/2008
 
100
98,205
 
5/20/2008
 
100
98,105
 
5/20/2008
 
2,100
96,005
 
5/20/2008
 
100
95,905
 
5/20/2008
 
100
95,805
 
5/20/2008
 
100
95,705
 
5/20/2008
 
1,900
93,805
 
5/20/2008
 
900
92,905
 
5/20/2008
 
4,100
88,805
 
5/20/2008
 
400
88,405
 
5/20/2008
 
700
87,705
 
5/20/2008
 
100
87,605
 
5/20/2008
 
2,000
85,605
 
5/20/2008
 
1,600
84,005
 
5/20/2008
 
100
83,905
 
5/20/2008
 
100
83,805
 
5/20/2008
 
1,500
82,305
 
5/20/2008
 
100
82,205
 
5/20/2008
 
1,600
80,605
 
5/20/2008
 
100
80,505
 
5/20/2008
 
100
80,405
 
5/20/2008
 
600
79,805
 
5/20/2008
 
1,000
78,805
 
5/20/2008
4,000
 
82,805
 
5/20/2008
5,000
 
87,805
 
5/20/2008
10,000
 
97,805
 
5/21/2008
 
1,400
96,405
 
5/21/2008
 
200
96,205
 
5/21/2008
 
800
95,405
 
5/21/2008
 
3,000
92,405
 
5/21/2008
 
100
92,305
 
5/21/2008
 
6,900
85,405
 
5/21/2008
1,300
 
86,705

 
72

 


 
5/21/2008
100
 
86,805
 
5/21/2008
500
 
87,305
 
5/22/2008
 
1,616
85,689
 
5/22/2008
 
100
85,589
 
5/22/2008
 
100
85,489
 
5/22/2008
 
584
84,905
 
5/22/2008
 
4,118
80,787
 
5/22/2008
 
200
80,587
 
5/22/2008
 
100
80,487
 
5/22/2008
 
100
80,387
 
5/22/2008
 
200
80,187
 
5/22/2008
 
100
80,087
 
5/22/2008
 
100
79,987
 
5/22/2008
 
82
79,905
 
5/27/2008
 
100
79,805
 
5/27/2008
 
100
79,705
 
5/27/2008
 
1,800
77,905
 
5/27/2008
 
100
77,805
 
5/27/2008
 
4,000
73,805
 
5/27/2008
 
100
73,705
 
5/27/2008
 
4,900
68,805
 
5/27/2008
 
100
68,705
 
5/27/2008
 
2,800
65,905
 
5/27/2008
 
3,600
62,305
 
5/27/2008
 
1,500
60,805
 
5/27/2008
 
200
60,605
 
5/27/2008
 
1,500
59,105
 
5/27/2008
 
100
59,005
 
5/27/2008
 
500
58,505
 
5/27/2008
 
100
58,405
 
5/27/2008
 
200
58,205
 
5/27/2008
 
100
58,105
 
5/27/2008
 
1,500
56,605
 
5/27/2008
300
 
56,905
 
5/27/2008
200
 
57,105
 
5/27/2008
300
 
57,405
 
5/27/2008
100
 
57,505
 
5/27/2008
600
 
58,105
 
5/27/2008
400
 
58,505
 
5/28/2008
3,100
 
61,605
 
5/28/2008
 
10,000
51,605
 
5/29/2008
 
1,259
50,346
 
5/29/2008
1,900
 
52,246
 
5/29/2008
1,000
 
53,246
 
5/29/2008
1,000
 
54,246
 
5/29/2008
100
 
54,346
 
6/6/2008
500
 
54,846
 
6/6/2008
500
 
55,346
 
6/6/2008
500
 
55,846

 
73

 


 
6/6/2008
500
 
56,346
 
6/6/2008
500
 
56,846
 
6/6/2008
500
 
57,346
 
6/6/2008
500
 
57,846
 
6/6/2008
500
 
58,346
 
6/6/2008
500
 
58,846
 
6/6/2008
500
 
59,346
 
6/9/2008
2,370
 
61,716
 
6/9/2008
130
 
61,846
 
6/10/2008
 
1,373
60,473
 
6/10/2008
 
3,627
56,846
 
6/11/2008
4,500
 
61,346
 
6/11/2008
100
 
61,446
 
6/11/2008
100
 
61,546
 
6/11/2008
300
 
61,846
 
6/11/2008
700
 
62,546
 
6/11/2008
1,540
 
64,086
 
6/11/2008
1,500
 
65,586
 
6/11/2008
445
 
66,031
 
6/11/2008
100
 
66,131
 
6/11/2008
465
 
66,596
 
6/16/2008
 
2,100
64,496
 
6/17/2008
 
4,400
60,096
 
6/19/2008
1,500
 
61,596
 
6/21/2008
500
 
62,096
 
6/24/2008
4,500
 
66,596
 
6/24/2008
200
 
66,796
 
6/24/2008
100
 
66,896
 
6/24/2008
100
 
66,996
 
6/24/2008
100
 
67,096
 
6/24/2008
1,500
 
68,596
 
6/24/2008
100
 
68,696
 
6/24/2008
5,000
 
73,696
 
6/24/2008
2,900
 
76,596
 
6/24/2008
100
 
76,696
 
6/24/2008
300
 
76,996
 
6/24/2008
300
 
77,296
 
6/24/2008
800
 
78,096
 
6/25/2008
500
 
78,596
 
6/25/2008
500
 
79,096
 
6/26/2008
900
 
79,996
 
6/26/2008
600
 
80,596
 
6/26/2008
2,500
 
83,096
 
6/26/2008
1,500
 
84,596
 
6/26/2008
600
 
85,196
 
6/26/2008
900
 
86,096
 
6/26/2008
1,000
 
87,096
 
6/26/2008
1,000
 
88,096
 
6/26/2008
300
 
88,396

 
74

 


 
6/26/2008
100
 
88,496
 
6/26/2008
100
 
88,596
 
6/26/2008
1,600
 
90,196
 
6/26/2008
200
 
90,396
 
6/26/2008
100
 
90,496
 
6/26/2008
100
 
90,596
 
6/27/2008
 
100
90,496
 
6/27/2008
 
1,000
89,496
 
6/27/2008
 
500
88,996
 
6/27/2008
 
500
88,496
 
6/27/2008
 
500
87,996
 
6/27/2008
 
500
87,496
 
6/27/2008
 
500
86,996
 
6/27/2008
 
500
86,496
 
6/27/2008
 
500
85,996
 
6/27/2008
 
500
85,496
 
6/27/2008
 
500
84,996
 
6/27/2008
 
100
84,896
 
6/27/2008
 
500
84,396
 
6/27/2008
 
3,800
80,596
 
6/27/2008
100
 
80,696
 
6/27/2008
400
 
81,096
 
6/27/2008
100
 
81,196
 
6/27/2008
400
 
81,596
 
6/27/2008
4,000
 
85,596
 
6/27/2008
200
 
85,796
 
6/27/2008
600
 
86,396
 
6/27/2008
100
 
86,496
 
6/27/2008
200
 
86,696
 
6/27/2008
300
 
86,996
 
6/27/2008
100
 
87,096
 
6/27/2008
2,500
 
89,596
 
6/27/2008
300
 
89,896
 
6/27/2008
100
 
89,996
 
6/27/2008
100
 
90,096
 
6/27/2008
2,500
 
92,596
 
6/27/2008
100
 
92,696
 
6/27/2008
100
 
92,796
 
6/27/2008
100
 
92,896
 
6/27/2008
1,700
 
94,596
 
6/27/2008
200
 
94,796
 
6/27/2008
300
 
95,096
 
6/27/2008
500
 
95,596
 
6/27/2008
400
 
95,996
 
6/27/2008
100
 
96,096
 
6/27/2008
100
 
96,196
 
6/27/2008
100
 
96,296
 
6/27/2008
1,300
 
97,596
 
6/30/2008
1,660
 
99,256

 
75

 


 
6/30/2008
340
 
99,596
 
6/30/2008
500
 
100,096
 
6/30/2008
100
 
100,196
 
6/30/2008
100
 
100,296
 
6/30/2008
100
 
100,396
 
6/12/2008
2,500
 
102,896
 
6/12/2008
4,513
 
107,409
 
6/12/2008
387
 
107,796
 
6/12/2008
300
 
108,096
 
6/12/2008
300
 
108,396
 
6/12/2008
10,000
 
118,396
 
6/13/2008
200
 
118,596
 
6/16/2008
 
600
117,996
 
6/16/2008
 
100
117,896
 
6/16/2008
 
1,800
116,096
 
6/16/2008
 
3,900
112,196
 
6/16/2008
 
100
112,096
 
6/16/2008
 
100
111,996
 
6/16/2008
 
200
111,796
 
6/16/2008
 
700
111,096
 
6/17/2008
2,500
 
113,596
 
6/17/2008
1,500
 
115,096
 
6/17/2008
700
 
115,796
 
6/18/2008
2,500
 
118,296
 
6/18/2008
2,500
 
120,796
 
6/18/2008
500
 
121,296
 
6/18/2008
200
 
121,496
 
6/18/2008
150
 
121,646
 
6/19/2008
2,400
 
124,046
 
6/19/2008
400
 
124,446
 
6/19/2008
2,200
 
126,646
 
6/19/2008
1,000
 
127,646
 
6/19/2008
200
 
127,846
 
6/19/2008
100
 
127,946
 
6/19/2008
2,300
 
130,246
 
6/19/2008
200
 
130,446
 
6/19/2008
1,200
 
131,646
 
6/19/2008
100
 
131,746
 
6/19/2008
100
 
131,846
 
6/19/2008
100
 
131,946
 
6/20/2008
 
1,000
130,946
 
6/20/2008
 
1,100
129,846
 
6/20/2008
 
200
129,646
 
6/20/2008
 
200
129,446
 
6/20/2008
 
2,250
127,196
 
6/20/2008
 
3,500
123,696
 
6/20/2008
 
300
123,396
 
6/20/2008
 
800
122,596
 
6/20/2008
 
400
122,196

 
76

 


 
6/20/2008
 
600
121,596
 
6/20/2008
 
300
121,296
 
6/20/2008
 
1,000
120,296
 
6/20/2008
 
300
119,996
 
6/20/2008
 
100
119,896
 
6/20/2008
 
100
119,796
 
6/20/2008
 
100
119,696
 
6/20/2008
 
2,000
117,696
 
6/20/2008
 
100
117,596
 
6/20/2008
 
34
117,562
 
6/20/2008
 
1,500
116,062
 
6/20/2008
 
1,366
114,696
 
6/20/2008
300
 
114,996
 
6/20/2008
1,300
 
116,296
 
6/20/2008
3,400
 
119,696
 
6/20/2008
100
 
119,796
 
6/20/2008
100
 
119,896
 
6/20/2008
200
 
120,096
 
6/20/2008
2,100
 
122,196
 
6/20/2008
100
 
122,296
 
6/20/2008
600
 
122,896
 
6/20/2008
100
 
122,996
 
6/20/2008
1,700
 
124,696
 
6/20/2008
500
 
125,196
 
6/20/2008
500
 
125,696
 
6/20/2008
100
 
125,796
 
6/23/2008
 
2,000
123,796
 
6/23/2008
 
1,000
122,796
 
6/23/2008
 
2,500
120,296
 
6/23/2008
 
38
120,258
 
6/23/2008
 
4,962
115,296
 
6/23/2008
 
1,000
114,296
 
6/23/2008
 
75
114,221
 
6/23/2008
 
30
114,191
 
6/23/2008
 
90
114,101
 
6/23/2008
 
515
113,586
 
6/23/2008
 
1,115
112,471
 
6/23/2008
 
140
112,331
 
6/23/2008
 
50
112,281
 
6/23/2008
 
800
111,481
 
6/23/2008
 
1,185
110,296
 
6/23/2008
100
 
110,396
 
6/23/2008
4,900
 
115,296
 
6/30/2008
500
 
115,796
 
6/30/2008
2,000
 
117,796
 
6/30/2008
300
 
118,096
 
6/30/2008
200
 
118,296
 
6/30/2008
200
 
118,496
 
6/30/2008
2,600
 
121,096

 
77

 


 
6/30/2008
100
 
121,196
 
6/30/2008
100
 
121,296
 
6/30/2008
300
 
121,596
 
7/1/2008
1,000
 
122,596
 
7/1/2008
100
 
122,696
 
7/1/2008
100
 
122,796
 
7/1/2008
600
 
123,396
 
7/1/2008
500
 
123,896
 
7/1/2008
100
 
123,996
 
7/1/2008
100
 
124,096
 
7/1/2008
100
 
124,196
 
7/1/2008
100
 
124,296
 
7/1/2008
100
 
124,396
 
7/1/2008
100
 
124,496
 
7/1/2008
100
 
124,596
 
7/2/2008
3,600
 
128,196
 
7/2/2008
1,900
 
130,096
 
7/2/2008
1,000
 
131,096
 
7/2/2008
200
 
131,296
 
7/2/2008
300
 
131,596
 
7/8/2008
 
4,000
127,596
 
7/8/2008
1,500
 
129,096
 
7/8/2008
250
 
129,346
 
7/9/2008
 
8,800
120,546
 
7/9/2008
 
1,200
119,346
 
7/9/2008
 
100
119,246
 
7/9/2008
 
1,400
117,846
 
7/9/2008
250
 
118,096
 
7/9/2008
300
 
118,396
 
7/9/2008
250
 
118,646
 
7/9/2008
100
 
118,746
 
7/9/2008
100
 
118,846
 
7/9/2008
100
 
118,946
 
7/9/2008
200
 
119,146
 
7/9/2008
100
 
119,246
 
7/9/2008
400
 
119,646
 
7/9/2008
70
 
119,716
 
7/10/2008
2,500
 
122,216
 
7/10/2008
 
2,620
119,596
 
7/10/2008
1,500
 
121,096
 
7/10/2008
300
 
121,396
 
7/10/2008
700
 
122,096
 
7/10/2008
100
 
122,196
 
7/10/2008
100
 
122,296
 
7/11/2008
 
4,967
117,329
 
7/11/2008
 
33
117,296
 
7/11/2008
 
5,000
112,296
 
7/11/2008
 
7,000
105,296
 
7/11/2008
 
3,000
102,296

 
78

 


 
7/11/2008
 
30,500
71,796
 
7/11/2008
 
2,250
69,546
 
7/11/2008
 
2,500
67,046
 
7/11/2008
 
250
66,796
 
7/11/2008
300
 
67,096
 
7/11/2008
12,500
 
79,596
 
7/11/2008
100
 
79,696
 
7/11/2008
500
 
80,196
 
7/11/2008
500
 
80,696
 
7/11/2008
500
 
81,196
 
7/11/2008
500
 
81,696
 
7/11/2008
500
 
82,196
 
7/11/2008
1,000
 
83,196
 
7/11/2008
1,400
 
84,596
 
7/14/2008
2,207
 
86,803
 
7/14/2008
5,453
 
92,256
 
7/14/2008
100
 
92,356
 
7/14/2008
1,240
 
93,596
 
7/14/2008
100
 
93,696
 
7/14/2008
100
 
93,796
 
7/14/2008
1,800
 
95,596
 
7/14/2008
8,000
 
103,596
 
7/14/2008
500
 
104,096
 
7/14/2008
100
 
104,196
 
7/14/2008
100
 
104,296
 
7/16/2008
300
 
104,596
 
7/16/2008
1,000
 
105,596
 
7/16/2008
500
 
106,096
 
7/16/2008
100
 
106,196
 
7/16/2008
350
 
106,546
 
7/16/2008
700
 
107,246
 
7/16/2008
 
258
106,988
 
7/16/2008
 
1,500
105,488
 
7/16/2008
 
200
105,288
 
7/16/2008
 
92
105,196
 
7/16/2008
2,500
 
107,696
 
7/16/2008
100
 
107,796
 
7/16/2008
100
 
107,896
 
7/16/2008
400
 
108,296
 
7/16/2008
900
 
109,196
 
7/16/2008
2,500
 
111,696
 
7/16/2008
1,500
 
113,196
 
7/16/2008
100
 
113,296
 
7/16/2008
600
 
113,896
 
7/16/2008
100
 
113,996
 
7/16/2008
1,000
 
114,996
 
7/16/2008
1,600
 
116,596
 
7/17/2008
1,600
 
118,196
 
7/17/2008
2,500
 
120,696

 
79

 


 
7/17/2008
4,500
 
125,196
 
7/17/2008
5,000
 
130,196
 
7/17/2008
700
 
130,896
 
7/17/2008
4,300
 
135,196
 
7/17/2008
500
 
135,696
 
7/17/2008
49
 
135,745
 
7/17/2008
300
 
136,045
 
7/17/2008
2,242
 
138,287
 
7/17/2008
50
 
138,337
 
7/17/2008
1,651
 
139,988
 
7/17/2008
5,207
 
145,195
 
7/17/2008
1,200
 
146,395
 
7/17/2008
1,301
 
147,696
 
7/17/2008
500
 
148,196
 
7/17/2008
100
 
148,296
 
7/17/2008
100
 
148,396
 
7/17/2008
900
 
149,296
 
7/17/2008
900
 
150,196
 
7/18/2008
1,250
 
151,446
 
7/21/2008
100
 
151,546
 
7/21/2008
100
 
151,646
 
7/21/2008
200
 
151,846
 
7/21/2008
500
 
152,346
 
7/21/2008
100
 
152,446
 
7/21/2008
250
 
152,696
 
7/21/2008
1,000
 
153,696
 
7/21/2008
300
 
153,996
 
7/21/2008
200
 
154,196
 
7/22/2008
500
 
154,696
 
7/22/2008
100
 
154,796
 
7/22/2008
250
 
155,046
 
7/23/2008
 
5,000
150,046
 
7/23/2008
650
 
150,696
 
7/23/2008
100
 
150,796
 
7/23/2008
100
 
150,896
 
7/23/2008
300
 
151,196
 
7/23/2008
250
 
151,446
 
7/23/2008
500
 
151,946
 
7/23/2008
200
 
152,146
 
7/23/2008
250
 
152,396
 
7/24/2008
100
 
152,496
 
7/29/2008
400
 
152,896
 
7/29/2008
800
 
153,696
 
7/29/2008
200
 
153,896
 
7/29/2008
200
 
154,096
 
7/29/2008
4,500
 
158,596
 
7/29/2008
100
 
158,696
 
7/29/2008
400
 
159,096
 
7/29/2008
100
 
159,196

 
80

 


 
7/29/2008
500
 
159,696
 
7/29/2008
100
 
159,796
 
7/29/2008
100
 
159,896
 
7/29/2008
200
 
160,096
 
7/29/2008
100
 
160,196
 
7/29/2008
500
 
160,696
 
7/29/2008
100
 
160,796
 
7/29/2008
150
 
160,946
 
7/29/2008
250
 
161,196
 
7/31/2008
 
1,200
159,996
 
7/31/2008
 
300
159,696
 
7/31/2008
 
1,300
158,396
 
7/31/2008
 
200
158,196
 
8/1/2008
1,100
 
159,296
 
8/1/2008
100
 
159,396
 
8/1/2008
 
100
159,296
 
8/1/2008
 
100
159,196
 
8/1/2008
 
100
159,096
 
8/1/2008
 
100
158,996
 
8/1/2008
 
100
158,896
 
8/1/2008
 
200
158,696
 
8/1/2008
 
100
158,596
 
8/1/2008
 
500
158,096
 
8/4/2008
1,000
 
159,096
 
8/4/2008
300
 
159,396
 
8/4/2008
 
100
159,296
 
8/4/2008
 
100
159,196
 
8/4/2008
 
100
159,096
 
8/4/2008
 
100
158,996
 
8/4/2008
 
4,000
154,996
 
8/4/2008
 
100
154,896
 
8/4/2008
 
200
154,696
 
8/4/2008
 
39
154,657
 
8/4/2008
 
261
154,396
 
8/5/2008
300
 
154,696
 
8/5/2008
200
 
154,896
 
8/5/2008
100
 
154,996
 
8/5/2008
500
 
155,496
 
8/5/2008
200
 
155,696
 
8/5/2008
900
 
156,596
 
8/5/2008
500
 
157,096
 
8/5/2008
200
 
157,296
 
8/5/2008
200
 
157,496
 
8/5/2008
100
 
157,596
 
8/8/2008
500
 
158,096
 
8/8/2008
420
 
158,516
 
8/11/2008
2,388
 
160,904
 
8/11/2008
2,612
 
163,516
 
8/11/2008
2,500
 
166,016
 
8/11/2008
430
 
166,446
 
8/11/2008
1,100
 
167,546
 
8/11/2008
550
 
168,096
 
8/11/2008
1,500
 
169,596
 
8/12/2008
500
 
170,096
 
8/19/2008
300
 
170,396
 
8/19/2008
300
 
170,696
 
8/26/2008
400
 
171,096


 
81

 
 

Name and Business
Address
Transaction
Date
Number of Securities
Purchased
Number of Securities
Sold
Current
Ownership
Charles Schliebs1
411 Seventh Avenue
14th Floor
Pittsburgh, PA  15219
-
-
-
1,128
Terry Knapp, M.D.
7451 N. 63rd Street
Niwot, CO 80503
N/A
0
0
0
Robert Binkele2
73061 El Paseo, Suite 210
Palm Desert, CA 92260
 
12/22/2006
12/26/2006
12/27/2006
12/28/2006
1/8/2007
1/26/2007
1/29/2007
1/30/2007
1/31/2007
2/2/2007
2/5/2007
2/12/2007
2/13/2007
2/14/2007
2/26/2007
3/5/2007
3/29/2007
4/13/2007
4/17/2007
4/19/2007
4/30/2007
5/1/2007
1,000
2,000
8,000
862
1,000
2,000
6,000
4,100
4,100
1,730
2,696
4,000
4,000
8,000
2,000
2,000
3,000
5,000
8,000
1,000
5,000
3,100
0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
________________________
1 Charles Schliebs controls 1,128 shares of common stock of the Company held by iNetworks, LLC. 
2 Robert Binkele controls 58,000 shares of common stock of the Company held by Telibrick, Inc.
 
82

 
Name and Business
Address
Transaction
Date
Number of Securities
Purchased
Number of Securities
Sold
Current
Ownership
Robert Binkele2 
73061 El Paseo, Suite 210
Palm Desert, CA 92260
(continued)
 
 
5/9/2007
5/14/2007
5/15/2007
5/31/2007
6/1/2007
6/6/2007
6/8/2007
6/17/2008
10,000
4,000
300
1,500
3,100
1,000
900
5,900
 
 
 
 
 
 
 
105,288
Barry Vogel3
5353 Thimens Blvd.
Saint-Laurent, Quebec H4R 2H4, Canada
12/12/2006
5/1/2007
7/26/2007
29,411
5,882
 
 
20,000
 
 
 
15,293
Eric Donsky
12707 High Bluff Dr., Suite 200
San Diego, CA 92130
 
N/A
0
0
0
Dr. Johan Brahme
 
11/24/04
12/22/05
5/2/07
5/3/07
 
 29,411
7,058
4,500
4,500
 
45,469
 
 

 
83

 
 
 
PROXY CARD

ARTES MEDICAL, INC.
ANNUAL MEETING OF STOCKHOLDERS

THIS PROXY IS SOLICITED BY DR. H. MICHAEL SHACK

The undersigned hereby, with respect to all shares of Common Stock of Artes Medical, Inc. (the "Company") which the undersigned may be entitled to vote, constitutes and appoints Dr. H. Michael Shack as his true and lawful agent and proxy, with full power of substitution, to represent the undersigned at the Annual Meeting of Stockholders of the Company to be held at the San Diego Marriott Del Mar located at 11966 El Camino Real, San Diego, California 92130 on October 30, 2008 at 9:00AM, and at any adjournments or postponements thereof, to vote such stock on all matters coming before said meeting as set forth below:

THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER MARKED HEREIN BY THE UNDERSIGNED STOCKHOLDER. IF NO MARKINGS ARE MADE, THIS PROXY WILL BE DEEMED TO BE A DIRECTION TO VOTE FOR ALL NOMINEES FOR DIRECTOR. PLEASE MARK THIS BLUE PROXY CARD, FILL IN THE DATE, SIGN ON THE REVERSE SIDE AND RETURN PROMPTLY IN THE ACCOMPANYING ENVELOPE. NO POSTAGE IS NECESSARY IF MAILED IN THE UNITED STATES.

[X] PLEASE MARK YOUR VOTE AS IN THIS EXAMPLE.

DR. H. MICHAEL SHACK RECOMMENDS A VOTE FOR THE FOLLOWING PROPOSALS

1.  First Amendment to Bylaws.  Amend the Bylaws of the Company (the "Bylaws") to allow the Stockholders to fill vacancies on the Board of Directors resulting from the removal of any Directors.

[   ] For

[   ] Against

[   ] Withhold Authority

2.  Second Amendment to Bylaws.  Amend the Bylaws to allow the Stockholders to increase the number of directorships of the Board of Directors to 11.

[   ] For

[   ] Against

[   ] Withhold Authority

 


3.  Removal of Directors.  Remove three of the current members of the Board of Directors of the Company under Delaware General Corporation Law §141(k)(1) for cause.

[   ] For removal of all Directors Listed Below (except as marked to the contrary below)

[   ] Against removal of all Directors Listed Below

[   ] Withhold Authority (to vote for removal of all Directors listed below)

(To withhold authority to vote for any individual, strike a line through the name below)

Lon E. Otremba
Beverly A. Huss
Robert B. Shermano

4.  Election of Directors.  Elect three or four new Directors of the Company to fill the vacancies on the Board of Directors by the amendment to the bylaws to increase the number of Directors in proposal #2 or the removal of three directors in Proposal #3.  The three or four new Directors will serve until their respective Class terms expire or until their successors are duly elected and qualified.  Should proposal #2 be unsuccessful, Dr. Johan Brahme will be removed as a Nominee

[   ] For all Nominees Listed Below (except as marked to the contrary below)

[   ] Against election of all Nominees Listed Below

[   ] Withhold Authority (to vote for all nominees listed below)

(To withhold authority to vote for any individual nominee, strike a line through the nominees name below)

Barry Vogel
Terry Knapp, M.D.
Eric Donsky
Dr. Johan Brahme

5.  Election of Class II Directors.  Elect two Class II Directors to serve for three year terms until the annual meeting of Stockholders in 2011 or until their successors are duly elected and qualified.

[   ] For election of all Nominees Listed Below (except as marked to the contrary below)

[   ] Against election of all Nominees Listed Below

[   ] Withhold Authority (to vote for all nominees listed below)



 
(To withhold authority to vote for any individual nominee, strike a line through the nominees name below)

Charles A. Schliebs
Robert Binkele

6.  Proposed Financing.  Vote on the Nominees’ proposal that the Company sell up to $20,000,000 of its securities to investors from time to time pursuant to one or more financing transactions

[   ] For

[   ] Against

[   ] Withhold Authority


When shares are held by joint tenants, both should sign. When signing as attorney-in-fact, executor, administrator, trustee, guardian, corporate officer or partner, please give full title as such.  If a corporation, please sign in corporate name of President or other authorized officer. If a partnership, please sign a partnership name by authorized person.
 

__________________________________
Signature(s) of Stockholder(s)
__________________________________
Title, if any
Date:  _____________________________